| 1 | Clonal Hematopoiesis of Indeterminate Potential and Long-term Outcomes in Heart Transplantation | 1.8 | 5 | Citations (PDF) |
| 2 | Clonal Hematopoiesis of Indeterminate Potential | 11.1 | 4 | Citations (PDF) |
| 3 | PCSK9 in metabolism and diseases | 9.1 | 45 | Citations (PDF) |
| 4 | Happy birthday, Dr Braunwald! | 2.2 | 2 | Citations (PDF) |
| 5 | Changes in Blood Eosinophil Counts Predict the Death of Patients With Myocardial Infarction After Hospital Discharge | 4.0 | 6 | Citations (PDF) |
| 6 | Associations of Serum Urate and Cardiovascular Events in a Clinical Trial of Interleukin-1β Blockade | 1.3 | 1 | Citations (PDF) |
| 7 | Potential Impact of Colchicine on Atherosclerotic Cardiovascular Disease in the United States | 1.3 | 9 | Citations (PDF) |
| 8 | A Protein Corona‐Based Diagnostic Tool for Eroded Atherosclerotic Plaques | 11.5 | 1 | Citations (PDF) |
| 9 | Acute coronary syndromes: mechanisms, challenges, and new opportunities | 2.2 | 74 | Citations (PDF) |
| 10 | Addition of eicosapentaenoic acid (EPA) to a GLP-1 agonist increased expression of an endothelial antioxidant response element (ARE) protein in a synergistic fashion during inflammation | 1.5 | 0 | Citations (PDF) |
| 11 | Managing Cardiovascular Risk in Clonal Hematopoiesis of Indeterminate Potential | 4.6 | 2 | Citations (PDF) |
| 12 | Inflammation in acute myocardial infarction: the good, the bad and the ugly | 2.2 | 311 | Citations (PDF) |
| 13 | Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13 970 Contemporary High-Risk Patients With Statin Intolerance | 18.0 | 122 | Citations (PDF) |
| 14 | Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias | 2.2 | 76 | Citations (PDF) |
| 15 | Inflammation and the pathogenesis of atherosclerosis | 2.5 | 79 | Citations (PDF) |
| 16 | Do patients benefit from omega-3 fatty acids? | 5.5 | 59 | Citations (PDF) |
| 17 | Risk factors for clonal hematopoiesis of indeterminate potential in people with HIV: a report from the REPRIEVE trial | 5.0 | 10 | Citations (PDF) |
| 18 | International Atherosclerosis Society Roadmap for Familial Hypercholesterolaemia | 2.5 | 10 | Citations (PDF) |
| 19 | Segmentation of anatomical layers and imaging artifacts in intravascular polarization sensitive optical coherence tomography using attending physician and boundary cardinality losses | 2.8 | 5 | Citations (PDF) |
| 20 | Clonal Hematopoiesis of Indeterminate Potential With Loss of
Tet2
Enhances Risk for Atrial Fibrillation Through
Nlrp3
Inflammasome Activation | 18.0 | 78 | Citations (PDF) |
| 21 | Colchicine’s Role in Cardiovascular Disease Management | 6.0 | 80 | Citations (PDF) |
| 22 | Application of implementation science for improving the utilization of an international clinical practice guidance on familial hypercholesterolemia | 3.1 | 9 | Citations (PDF) |
| 23 | ASSOCIATIONS BETWEEN MOSAIC CHROMOSOMAL ALTERATIONS AND INCIDENT VENOUS THROMBOEMBOLISM IN THE MASS GENERAL BRIGHAM BIOBANK | 2.3 | 0 | Citations (PDF) |
| 24 | The clonal hematopoiesis mutation Jak2 aggravates endothelial injury and thrombosis in arteries with erosion-like intimas | 2.2 | 36 | Citations (PDF) |
| 25 | Eicosapentaenoic Acid Improves Endothelial Nitric Oxide Bioavailability Via Changes in Protein Expression During Inflammation | 4.0 | 28 | Citations (PDF) |
| 26 | Residual Inflammatory Risk in Outcomes of Chinese Patients After Percutaneous Coronary Intervention | 2.3 | 19 | Citations (PDF) |
| 27 | Inflammation unites diverse acute and chronic diseases | 3.0 | 37 | Citations (PDF) |
| 28 | Lessons from PROMINENT and prospects for pemafibrate | 9.4 | 13 | Citations (PDF) |
| 29 | Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trials | 33.0 | 41 | Citations (PDF) |
| 30 | Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial | 2.2 | 24 | Citations (PDF) |
| 31 | Drug-Drug Interactions and the Clinical Tolerability of Colchicine Among Patients With COVID-19 | 6.6 | 10 | Citations (PDF) |
| 32 | Long-term longitudinal analysis of 4,187 participants reveals insights into determinants of clonal hematopoiesis | 13.7 | 40 | Citations (PDF) |
| 33 | European Heart Journal: a call to action | 2.2 | 2 | Citations (PDF) |
| 34 | Differential roles of eosinophils in cardiovascular disease | 35.5 | 26 | Citations (PDF) |
| 35 | Clonal hematopoiesis and atherosclerosis | 10.6 | 51 | Citations (PDF) |
| 36 | Eosinophils protect pressure overload- and β-adrenoreceptor agonist-induced cardiac hypertrophy | 5.5 | 25 | Citations (PDF) |
| 37 | Group 2 innate lymphoid cells protect mouse heart from myocardial infarction injury via interleukin 5, eosinophils, and dendritic cells | 5.5 | 21 | Citations (PDF) |
| 38 | Cholesterol accumulation in macrophages drives NETosis in atherosclerotic plaques via IL-1β secretion | 5.5 | 89 | Citations (PDF) |
| 39 | Fundamental Pathobiology of Coronary Atherosclerosis and Clinical Implications for Chronic Ischemic Heart Disease Management—The Plaque Hypothesis | 11.1 | 215 | Citations (PDF) |
| 40 | TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease | 8.3 | 127 | Citations (PDF) |
| 41 | Eicosapentaenoic acid (EPA) reduces pulmonary endothelial dysfunction and inflammation due to changes in protein expression during exposure to particulate matter air pollution | 6.6 | 13 | Citations (PDF) |
| 42 | Why Y? The Y chromosome may serve a cardiovascular purpose after all | 2.2 | 4 | Citations (PDF) |
| 43 | A Nrf2-OSGIN1&2-HSP70 axis mediates cigarette smoke-induced endothelial detachment: implications for plaque erosion | 5.5 | 29 | Citations (PDF) |
| 44 | Vitamin D in atherosclerosis and cardiovascular events | 2.2 | 55 | Citations (PDF) |
| 45 | Comparative Effects of Mineral Oil, Corn Oil, Eicosapentaenoic Acid, and Docosahexaenoic Acid in an In Vitro Atherosclerosis Model | 4.0 | 22 | Citations (PDF) |
| 46 | Neutrophil to lymphocyte ratio predicts cardiovascular events in people with type 2 diabetes: Post hoc analysis of the
SUSTAIN
6 and
PIONEER
6 cardiovascular outcomes trials | 4.5 | 4 | Citations (PDF) |
| 47 | Blockade of IL-6 signaling alleviates atherosclerosis in Tet2-deficient clonal hematopoiesis | 8.3 | 69 | Citations (PDF) |
| 48 | International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia | 35.5 | 218 | Citations (PDF) |
| 49 | Culprit plaque morphology determines inflammatory risk and clinical outcomes in acute coronary syndrome | 2.2 | 53 | Citations (PDF) |
| 50 | Low-Density Lipoprotein Cholesterol Levels in Adults With Coronary Artery Disease in the US, January 2015 to March 2020 | 16.5 | 22 | Citations (PDF) |
| 51 | Differential Roles of Interleukin-6 in Severe Acute Respiratory Syndrome-Coronavirus-2 Infection and Cardiometabolic Diseases | 0.6 | 1 | Citations (PDF) |
| 52 | Genetic modification of inflammation- and clonal hematopoiesis–associated cardiovascular risk | 10.6 | 75 | Citations (PDF) |
| 53 | Quantitative imaging biomarkers of coronary plaque morphology: insights from EVAPORATE | 2.4 | 8 | Citations (PDF) |
| 54 | Loss-of-function mutations in Dnmt3a and Tet2 lead to accelerated atherosclerosis and concordant macrophage phenotypes | 8.3 | 27 | Citations (PDF) |
| 55 | Circulating Neutrophil-Related Proteins Associate with Incident Heart Failure and Cardiac Dysfunction: The ARIC Study | 7.3 | 13 | Citations (PDF) |
| 56 | Cellular Heterogeneity of Activated Primary Human Macrophages and Associated Drug–Gene Networks: From Biology to Precision Therapeutics | 18.0 | 24 | Citations (PDF) |
| 57 | Effects of IL-1β inhibition on anemia and clonal hematopoiesis in the randomized CANTOS trial | 5.0 | 45 | Citations (PDF) |
| 58 | Conquering cholesterol: a report from the front lines | 5.5 | 1 | Citations (PDF) |
| 59 | Coronavirus Disease 2019 (COVID-19) Coronary Vascular Thrombosis | 3.4 | 38 | Citations (PDF) |
| 60 | Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis | 5.5 | 102 | Citations (PDF) |
| 61 | Neutrophil extracellular traps: from physiology to pathology | 5.5 | 358 | Citations (PDF) |
| 62 | The dawn of a new era of targeted lipid-lowering therapies | 2.2 | 156 | Citations (PDF) |
| 63 | Early and late recurrent cardiovascular events among high‐risk patients with an acute coronary syndrome: Meta‐analysis of phase III studies and implications on trial design | 2.0 | 21 | Citations (PDF) |
| 64 | Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV | 3.4 | 63 | Citations (PDF) |
| 65 | The European Heart Journal: fulfilling the mission | 2.2 | 5 | Citations (PDF) |
| 66 | Prothymosin Alpha: A Novel Contributor to Estradiol Receptor Alpha–Mediated CD8
+
T-Cell Pathogenic Responses and Recognition of Type 1 Collagen in Rheumatic Heart Valve Disease | 18.0 | 44 | Citations (PDF) |
| 67 | Mischief in the marrow: a root of cardiovascular evil | 2.2 | 5 | Citations (PDF) |
| 68 | Cardiorenal risk of celecoxib compared with naproxen or ibuprofen in arthritis patients: insights from the PRECISION trial | 4.0 | 35 | Citations (PDF) |
| 69 | Inflammation, Aging, and Cardiovascular Disease | 2.3 | 410 | Citations (PDF) |
| 70 | B lymphocyte-derived acetylcholine limits steady-state and emergency hematopoiesis | 23.5 | 82 | Citations (PDF) |
| 71 | TET2-Driven Clonal Hematopoiesis and Response to Canakinumab | 11.1 | 354 | Citations (PDF) |
| 72 | Mendelian randomization supports bidirectional causality between telomere length and clonal hematopoiesis of indeterminate potential | 10.9 | 86 | Citations (PDF) |
| 73 | 1084: EICOSAPENTAENOIC ACID FAVORABLY MODULATES PROTEIN EXPRESSION IN PULMONARY ENDOTHELIAL INFLAMMATION | 0.5 | 0 | Citations (PDF) |
| 74 | 1082: EICOSAPENTAENOIC ACID INCREASES ENDOTHELIAL FUNCTION AND HEME OXYGENASE-1 IN PULMONARY INFLAMMATION | 0.5 | 0 | Citations (PDF) |
| 75 | 1081: EICOSAPENTAENOIC ACID REDUCES PULMONARY ENDOTHELIAL CELL ADHESION PROTEIN EXPRESSION WITH IL-6 | 0.5 | 1 | Citations (PDF) |
| 76 | Optical coherence tomography in coronary atherosclerosis assessment and intervention | 35.5 | 391 | Citations (PDF) |
| 77 | Genome-wide pleiotropy analysis of coronary artery disease and pneumonia identifies shared immune pathways | 10.9 | 9 | Citations (PDF) |
| 78 | Colony stimulating factor-1 producing endothelial cells and mesenchymal stromal cells maintain monocytes within a perivascular bone marrow niche | 22.6 | 64 | Citations (PDF) |
| 79 | ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future | 4.7 | 26 | Citations (PDF) |
| 80 | Allergic asthma is a risk factor for human cardiovascular diseases | 8.3 | 31 | Citations (PDF) |
| 81 | A biological rationale for the disparate effects of omega-3 fatty acids on cardiovascular disease outcomes | 2.7 | 38 | Citations (PDF) |
| 82 | Chasing LDL cholesterol to the bottom — PCSK9 in perspective | 8.3 | 37 | Citations (PDF) |
| 83 | Cardiovascular Disease in Myeloproliferative Neoplasms | 4.6 | 77 | Citations (PDF) |
| 84 | Eicosapentaenoic Acid (EPA) Modulates Expression of Inflammatory Proteins in Pulmonary Endothelial Cells following Exposure to Air Pollution Particles | 3.1 | 1 | Citations (PDF) |
| 85 | Inflammation drives residual risk in chronic kidney disease: a CANTOS substudy | 2.2 | 99 | Citations (PDF) |
| 86 | Pathway-Specific Polygenic Risk Scores Identify Obstructive Sleep Apnea–Related Pathways Differentially Moderating Genetic Susceptibility to Coronary Artery Disease | 2.9 | 32 | Citations (PDF) |
| 87 | A red wine intervention does not modify plasma trimethylamine N-oxide but is associated with broad shifts in the plasma metabolome and gut microbiota composition | 4.7 | 28 | Citations (PDF) |
| 88 | Biomarkers associated with coronary high-risk plaques | 1.9 | 24 | Citations (PDF) |
| 89 | Differential IL18 signaling via IL18 receptor and Na-Cl co-transporter discriminating thermogenesis and glucose metabolism regulation | 13.7 | 22 | Citations (PDF) |
| 90 | Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues | 4.7 | 116 | Citations (PDF) |
| 91 | Eosinophils Protect Mice From Angiotensin-II Perfusion–Induced Abdominal Aortic Aneurysm | 13.1 | 70 | Citations (PDF) |
| 92 | Premature Menopause, Clonal Hematopoiesis, and Coronary Artery Disease in Postmenopausal Women | 18.0 | 139 | Citations (PDF) |
| 93 | COVID-19 – A vascular disease | 7.2 | 313 | Citations (PDF) |
| 94 | Endotoxinemia Accelerates Atherosclerosis Through Electrostatic Charge–Mediated Monocyte Adhesion | 18.0 | 342 | Citations (PDF) |
| 95 | Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of bempedoic acid on cardiovascular events in patients with statin intolerance | 2.9 | 116 | Citations (PDF) |
| 96 | The cardiovascular–dialysis nexus: the transition to dialysis is a treacherous time for the heart | 2.2 | 24 | Citations (PDF) |
| 97 | The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis | 37.9 | 437 | Citations (PDF) |
| 98 | Targeted delivery of protein arginine deiminase-4 inhibitors to limit arterial intimal NETosis and preserve endothelial integrity | 5.5 | 54 | Citations (PDF) |
| 99 | Time-Restricted Salutary Effects of Blood Flow Restoration on Venous Thrombosis and Vein Wall Injury in Mouse and Human Subjects | 18.0 | 40 | Citations (PDF) |
| 100 | The changing landscape of atherosclerosis | 37.9 | 2,473 | Citations (PDF) |
| 101 | Targeting Inflammatory Pathways in Cardiovascular Disease: The Inflammasome, Interleukin-1, Interleukin-6 and Beyond | 4.6 | 133 | Citations (PDF) |
| 102 | Novel Lesional Transcriptional Signature Separates Atherosclerosis With and Without Diabetes in Yorkshire Swine and Humans | 6.0 | 7 | Citations (PDF) |
| 103 | Targeting inflammation in atherosclerosis — from experimental insights to the clinic | 79.7 | 922 | Citations (PDF) |
| 104 | IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial | 62.1 | 653 | Citations (PDF) |
| 105 | TNF‐α antagonism rescues the effect of ageing on stroke: Perspectives for targeting inflamm‐ageing | 3.0 | 49 | Citations (PDF) |
| 106 | Resilience of the Internal Mammary Artery to Atherogenesis: Shifting From Risk to Resistance to Address Unmet Needs | 6.0 | 60 | Citations (PDF) |
| 107 | Systems Approach to Discovery of Therapeutic Targets for Vein Graft Disease: PPARα Pivotally Regulates Metabolism, Activation, and Heterogeneity of Macrophages and Lesion Development | 18.0 | 40 | Citations (PDF) |
| 108 | Interleukins in cancer: from biology to therapy | 60.7 | 725 | Citations (PDF) |
| 109 | Near-Infrared Autofluorescence in Atherosclerosis Associates With Ceroid and Is Generated by Oxidized Lipid-Induced Oxidative Stress | 6.0 | 22 | Citations (PDF) |
| 110 | Acute mental stress drives vascular inflammation and promotes plaque destabilization in mouse atherosclerosis | 2.2 | 120 | Citations (PDF) |
| 111 | Latin American Consensus on management of residual cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic Risk (ALALIP) endorsed by the Inter-American Society of Cardiology (IASC), the International Atherosclerosis Society (IAS), and the Pan-American College of Endothelium (PACE) | 0.2 | 9 | Citations (PDF) |
| 112 | Ferritinophagy and ferroptosis in the management of metabolic diseases | 8.5 | 312 | Citations (PDF) |
| 113 | The JAK–STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms | 2.2 | 153 | Citations (PDF) |
| 114 | The role of eicosapentaenoic acid in reducing important cardiovascular events, including coronary revascularization | 5.6 | 20 | Citations (PDF) |
| 115 | Optical Coherence Tomography of Plaque Erosion | 2.3 | 41 | Citations (PDF) |
| 116 | Inflammation during the life cycle of the atherosclerotic plaque | 5.5 | 210 | Citations (PDF) |
| 117 | Association of Diet Quality With Prevalence of Clonal Hematopoiesis and Adverse Cardiovascular Events | 11.1 | 102 | Citations (PDF) |
| 118 | The changing
Nature
of atherosclerosis: what we thought we knew, what we think we know, and what we have to learn | 2.2 | 31 | Citations (PDF) |
| 119 | EPA and DHA containing phospholipids have contrasting effects on membrane structure | 3.6 | 88 | Citations (PDF) |
| 120 | The neutrophil–lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials | 2.2 | 321 | Citations (PDF) |
| 121 | Inflammation in Atherosclerosis—No Longer a Theory | 1.1 | 286 | Citations (PDF) |
| 122 | Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19 | 2.3 | 51 | Citations (PDF) |
| 123 | Highly Selective PPARα (Peroxisome Proliferator‐Activated Receptor α) Agonist Pemafibrate Inhibits Stent Inflammation and Restenosis Assessed by Multimodality Molecular‐Microstructural Imaging | 4.0 | 14 | Citations (PDF) |
| 124 | Immune and inflammatory mechanisms mediate cardiovascular diseases from head to toe | 5.5 | 15 | Citations (PDF) |
| 125 | 981: Eicosapentaenoic Acid Reduces Pulmonary Endothelial Caveolae Protein and Restores Nitric Oxide | 0.5 | 0 | Citations (PDF) |
| 126 | 980: Eicosapentaenoic Acid Reduces Pulmonary Endothelial Inflammation Caused by Cytokine Treatment | 0.5 | 0 | Citations (PDF) |
| 127 | 959: Eicosapentaenoic Acid Inhibits ICAM-1 Expression in Pulmonary Endothelial Cells With Inflammation | 0.5 | 0 | Citations (PDF) |
| 128 | The Pathogenesis of COVID-19 Myocardial Injury: An Immunohistochemical Study of Postmortem Biopsies | 4.9 | 35 | Citations (PDF) |
| 129 | COVID-19, the Pandemic of the Century and Its Impact on Cardiovascular Diseases | 0.6 | 7 | Citations (PDF) |
| 130 | Eicosapentaenoic acid Reduces Expression of Pulmonary Endothelial Angiotensin Converting Enzyme (ACE) Linked to Inflammation | 3.1 | 0 | Citations (PDF) |
| 131 | Bone marrow endothelial dysfunction promotes myeloid cell expansion in cardiovascular disease | 8.3 | 79 | Citations (PDF) |
| 132 | Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis | 2.2 | 217 | Citations (PDF) |
| 133 | Genetic Interleukin 6 Signaling Deficiency Attenuates Cardiovascular Risk in Clonal Hematopoiesis | 18.0 | 424 | Citations (PDF) |
| 134 | A new opening on aortic stenosis: predicting prognosis with clonal haematopoiesis | 2.2 | 3 | Citations (PDF) |
| 135 | Adipocytes promote interleukin-18 binding to its receptors during abdominal aortic aneurysm formation in mice | 2.2 | 59 | Citations (PDF) |
| 136 | Effects of Interleukin-1β Inhibition on Blood Pressure, Incident Hypertension, and Residual Inflammatory Risk | 6.6 | 116 | Citations (PDF) |
| 137 | Retinoids Repress Human Cardiovascular Cell Calcification With Evidence for Distinct Selective Retinoid Modulator Effects | 6.0 | 30 | Citations (PDF) |
| 138 | Differential immunological signature at the culprit site distinguishes acute coronary syndrome with intact from acute coronary syndrome with ruptured fibrous cap: results from the prospective translational OPTICO-ACS study | 2.2 | 101 | Citations (PDF) |
| 139 | Postischemic Administration of IL-1α Neutralizing Antibody Reduces Brain Damage and Neurological Deficit in Experimental Stroke | 18.0 | 34 | Citations (PDF) |
| 140 | Prospective Evaluation of Clinico-Pathological Predictors of Postoperative Atrial Fibrillation | 6.1 | 12 | Citations (PDF) |
| 141 | Paclitaxel Drug-Coated Balloon Angioplasty Suppresses Progression and Inflammation of Experimental Atherosclerosis in Rabbits | 3.3 | 46 | Citations (PDF) |
| 142 | Oxidized Low‐Density Lipoprotein Induces Macrophage Production of Prothrombotic Microparticles | 4.0 | 15 | Citations (PDF) |
| 143 | The European Heart Journal: leading the fight to reduce the global burden of cardiovascular disease | 2.2 | 9 | Citations (PDF) |
| 144 | COVID-19 is, in the end, an endothelial disease | 2.2 | 882 | Citations (PDF) |
| 145 | Inhibition of Interleukin-1β and Reduction in Atherothrombotic Cardiovascular Events in the CANTOS Trial | 2.3 | 197 | Citations (PDF) |
| 146 | Annexin A1–dependent tethering promotes extracellular vesicle aggregation revealed with single–extracellular vesicle analysis | 10.9 | 112 | Citations (PDF) |
| 147 | Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019 2020, 2, e0178 | | 41 | Citations (PDF) |
| 148 | Eosinophils improve cardiac function after myocardial infarction | 13.7 | 125 | Citations (PDF) |
| 149 | Reduced Nhe1 (Na
+
-H
+
Exchanger-1) Function Protects ApoE-Deficient Mice From Ang II (Angiotensin II)–Induced Abdominal Aortic Aneurysms | 6.6 | 11 | Citations (PDF) |
| 150 | Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients 2020, 213, 107587 | | 256 | Citations (PDF) |
| 151 | The Clinical Challenge of Clonal Hematopoiesis, a Newly Recognized Cardiovascular Risk Factor | 11.1 | 44 | Citations (PDF) |
| 152 | S100A9-RAGE Axis Accelerates Formation of Macrophage-Mediated Extracellular Vesicle Microcalcification in Diabetes Mellitus | 6.0 | 92 | Citations (PDF) |
| 153 | Gaps in beliefs and practice in dyslipidaemia management in Japan, Germany, Colombia and the Philippines: insights from a web-based physician survey | 3.8 | 9 | Citations (PDF) |
| 154 | Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid | 6.0 | 371 | Citations (PDF) |
| 155 | Antibody-based immunotherapy targeting cytokines and atherothrombotic cardiovascular diseases | 1.5 | 13 | Citations (PDF) |
| 156 | Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease | 2.2 | 314 | Citations (PDF) |
| 157 | Neutrophil Extracellular Traps Participate in Cardiovascular Diseases | 13.1 | 367 | Citations (PDF) |
| 158 | How Far We Have Come, How Far We Have Yet to Go in Atherosclerosis Research | 13.1 | 14 | Citations (PDF) |
| 159 | Bone Marrow Endothelial Cells Regulate Myelopoiesis in Diabetes Mellitus | 18.0 | 66 | Citations (PDF) |
| 160 | Atorvastatin Reduces In Vivo Fibrin Deposition and Macrophage Accumulation, and Improves Primary Patency Duration and Maturation of Murine Arteriovenous Fistula | 0.4 | 18 | Citations (PDF) |
| 161 | A tale of two therapies lipid-lowering vs. anti-inflammatory therapy: a false dichotomy? | 4.0 | 14 | Citations (PDF) |
| 162 | Long noncoding RNA
SNHG12
integrates a DNA-PK–mediated DNA damage response and vascular senescence | 12.5 | 133 | Citations (PDF) |
| 163 | LncRNA VINAS regulates atherosclerosis by modulating NF-κB and MAPK signaling | 5.4 | 74 | Citations (PDF) |
| 164 | Atherosclerosis | 46.9 | 2,847 | Citations (PDF) |
| 165 | Anticytokine Immune Therapy and Atherothrombotic Cardiovascular Risk | 6.0 | 77 | Citations (PDF) |
| 166 | Clonal Hematopoiesis | 2.3 | 234 | Citations (PDF) |
| 167 | Low-Density Lipoprotein Cholesterol After an Acute Coronary Syndrome: How Low to Go? | 2.9 | 7 | Citations (PDF) |
| 168 | Exercise reduces inflammatory cell production and cardiovascular inflammation via instruction of hematopoietic progenitor cells | 33.0 | 270 | Citations (PDF) |
| 169 | Tissue-Specific Macrophage Responses to Remote Injury Impact the Outcome of Subsequent Local Immune Challenge | 22.6 | 174 | Citations (PDF) |
| 170 | Leaders in Cardiovascular Research: Peter Libby | 5.5 | 2 | Citations (PDF) |
| 171 | Differential Roles of Cysteinyl Cathepsins in TGF-β Signaling and Tissue Fibrosis | 3.5 | 47 | Citations (PDF) |
| 172 | Na+-H+ exchanger 1 determines atherosclerotic lesion acidification and promotes atherogenesis | 13.7 | 44 | Citations (PDF) |
| 173 | From Focal Lipid Storage to Systemic Inflammation | 2.3 | 273 | Citations (PDF) |
| 174 | Self-reactive CD4+ IL-3+ T cells amplify autoimmune inflammation in myocarditis by inciting monocyte chemotaxis | 9.3 | 52 | Citations (PDF) |
| 175 | Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease | 37.9 | 174 | Citations (PDF) |
| 176 | Stage-dependent differential effects of interleukin-1 isoforms on experimental atherosclerosis | 2.2 | 126 | Citations (PDF) |
| 177 | Targeting RNA to lower triglycerides: long strides from short molecules | 2.2 | 12 | Citations (PDF) |
| 178 | Immunometabolism and atherosclerosis: perspectives and clinical significance: a position paper from the Working Group on Atherosclerosis and Vascular Biology of the European Society of Cardiology | 5.5 | 88 | Citations (PDF) |
| 179 | The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential | 9.4 | 127 | Citations (PDF) |
| 180 | Residual vascular risk in diabetes – Will the SPPARM alpha concept hold the key? | 3.0 | 6 | Citations (PDF) |
| 181 | Johann Sebastian Bach | 13.1 | 1 | Citations (PDF) |
| 182 | Novel Antiatherosclerotic Therapies | 6.0 | 134 | Citations (PDF) |
| 183 | Inflammation: a common contributor to cancer, aging, and cardiovascular diseases—expanding the concept of cardio-oncology | 5.5 | 175 | Citations (PDF) |
| 184 | Dietary cholesterol is essential to mast cell activation and associated obesity and diabetes in mice | 4.1 | 26 | Citations (PDF) |
| 185 | Dysregulation of IL-33/ST2 signaling and myocardial periarteriolar fibrosis | 3.8 | 24 | Citations (PDF) |
| 186 | Once more unto the breach: endothelial permeability and atherogenesis | 2.2 | 22 | Citations (PDF) |
| 187 | Sleep modulates haematopoiesis and protects against atherosclerosis | 37.9 | 420 | Citations (PDF) |
| 188 | Interleukin-1β Mediates Arterial Thrombus Formation via NET-Associated Tissue Factor | 2.5 | 83 | Citations (PDF) |
| 189 | Inhibiting NLRP3 Inflammasome Activity in Acute Myocardial Infarction: A Review of Pharmacologic Agents and Clinical Outcomes | 2.0 | 29 | Citations (PDF) |
| 190 | Low-Dose Methotrexate for the Prevention of Atherosclerotic Events | 34.5 | 1,200 | Citations (PDF) |
| 191 | Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure | 18.0 | 611 | Citations (PDF) |
| 192 | Cathepsin K-deficiency impairs mouse cardiac function after myocardial infarction | 3.8 | 34 | Citations (PDF) |
| 193 | Reassessing the Mechanisms of Acute Coronary Syndromes | 13.1 | 468 | Citations (PDF) |
| 194 | Deficiency of mouse mast cell protease 4 mitigates cardiac dysfunctions in mice after myocardium infarction | 4.1 | 9 | Citations (PDF) |
| 195 | Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease | 35.5 | 363 | Citations (PDF) |
| 196 | Elevations in neutrophils with obstructive sleep apnea: The Multi-Ethnic Study of Atherosclerosis (MESA) | 2.2 | 37 | Citations (PDF) |
| 197 | Cysteine protease cathepsins in cardiovascular disease: from basic research to clinical trials | 35.5 | 191 | Citations (PDF) |
| 198 | The potential benefits of aspirin for primary cardiovascular prevention in rheumatoid arthritis: a secondary analysis of the PRECISION Trial | 1.9 | 7 | Citations (PDF) |
| 199 | Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen | 2.3 | 43 | Citations (PDF) |
| 200 | Casting NETs to predict cardiovascular outcomes | 2.0 | 4 | Citations (PDF) |
| 201 | Nonculprit Plaque Characteristics in Patients With Acute Coronary Syndrome Caused by Plaque Erosion vs Plaque Rupture | 11.1 | 89 | Citations (PDF) |
| 202 | A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense | 13.7 | 98 | Citations (PDF) |
| 203 | Coronary Plaque Microstructure and Composition Modify Optical Polarization | 6.1 | 72 | Citations (PDF) |
| 204 | Differences in Safety of Nonsteroidal Antiinflammatory Drugs in Patients With Osteoarthritis and Patients With Rheumatoid Arthritis | 6.1 | 48 | Citations (PDF) |
| 205 | Plaque erosion: a new in vivo diagnosis and a potential major shift in the management of patients with acute coronary syndromes | 2.2 | 193 | Citations (PDF) |
| 206 | Adaptive immunity in acute coronary syndromes: chicken or egg? | 2.2 | 7 | Citations (PDF) |
| 207 | Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes | 2.3 | 310 | Citations (PDF) |
| 208 | Roles of PAD4 and NETosis in Experimental Atherosclerosis and Arterial Injury | 13.1 | 298 | Citations (PDF) |
| 209 | Pleiotropic Anti-atherosclerotic Effects of PCSK9 Inhibitors From Molecular Biology to Clinical Translation | 4.7 | 91 | Citations (PDF) |
| 210 | Epigenetics and precision medicine in cardiovascular patients: from basic concepts to the clinical arena | 2.2 | 117 | Citations (PDF) |
| 211 | Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial | 62.1 | 841 | Citations (PDF) |
| 212 | Fish Oil and Perioperative Bleeding | 4.1 | 63 | Citations (PDF) |
| 213 | Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery | 11.3 | 23 | Citations (PDF) |
| 214 | Medical Therapy for Long-Term Prevention of Atherothrombosis Following an Acute Coronary Syndrome | 2.3 | 91 | Citations (PDF) |
| 215 | Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study | 2.9 | 299 | Citations (PDF) |
| 216 | Inflammation, Immunity, and Infection in Atherothrombosis | 2.3 | 517 | Citations (PDF) |
| 217 | Relationship of Interleukin-1β Blockade With Incident Gout and Serum Uric Acid Levels | 9.6 | 97 | Citations (PDF) |
| 218 | Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease | 2.3 | 272 | Citations (PDF) |
| 219 | Mécanismes d’érosion superficielle des plaques d’athérosclérose | 0.0 | 0 | Citations (PDF) |
| 220 | Neutrophil Extracellular Traps Induce Endothelial Cell Activation and Tissue Factor Production Through Interleukin-1α and Cathepsin G | 6.0 | 328 | Citations (PDF) |
| 221 | Atherosclerosis and inflammation: overview and updates | 6.2 | 655 | Citations (PDF) |
| 222 | Association between Obstructive Sleep Apnea and Cardiovascular Risk Factors: Variation by Age, Sex, and Race. The Multi-Ethnic Study of Atherosclerosis | 3.4 | 91 | Citations (PDF) |
| 223 | Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS) | 2.2 | 534 | Citations (PDF) |
| 224 | Combined non-invasive assessment of endothelial shear stress and molecular imaging of inflammation for the prediction of inflamed plaque in hyperlipidaemic rabbit aortas | 1.4 | 19 | Citations (PDF) |
| 225 | Superficial erosion and the precision management of acute coronary syndromes: not one-size-fits-all | 2.2 | 38 | Citations (PDF) |
| 226 | The Aging Cardiovascular System | 2.3 | 580 | Citations (PDF) |
| 227 | Macrophages Facilitate Electrical Conduction in the HeartCell, 2017, 169, 510-522.e20 | 33.6 | 972 | Citations (PDF) |
| 228 | Interferon-γ Released by Activated CD8+ T Lymphocytes Impairs the Calcium Resorption Potential of Osteoclasts in Calcified Human Aortic Valves | 3.4 | 62 | Citations (PDF) |
| 229 | Flow Perturbation Mediates Neutrophil Recruitment and Potentiates Endothelial Injury via TLR2 in Mice | 13.1 | 190 | Citations (PDF) |
| 230 | Atheroma Susceptible to Thrombosis Exhibit Impaired Endothelial Permeability In Vivo as Assessed by Nanoparticle-Based Fluorescence Molecular Imaging | 2.9 | 48 | Citations (PDF) |
| 231 | Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease | 34.5 | 2,526 | Citations (PDF) |
| 232 | Ischemia and No Obstructive Coronary Artery Disease (INOCA) | 18.0 | 720 | Citations (PDF) |
| 233 | The infarcted myocardium solicits GM-CSF for the detrimental oversupply of inflammatory leukocytes | 9.3 | 207 | Citations (PDF) |
| 234 | Interleukin-1 Beta as a Target for Atherosclerosis Therapy | 2.3 | 618 | Citations (PDF) |
| 235 | Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial | 62.1 | 1,265 | Citations (PDF) |
| 236 | Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease | 34.5 | 8,752 | Citations (PDF) |
| 237 | Tilting at the tilted protease balance in arterial aneurysmal disease | 5.5 | 4 | Citations (PDF) |
| 238 | Acute Coronary Syndromes | 18.0 | 452 | Citations (PDF) |
| 239 | IRF3 and type I interferons fuel a fatal response to myocardial infarction | 33.0 | 554 | Citations (PDF) |
| 240 | Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN | 1.5 | 43 | Citations (PDF) |
| 241 | Mechanisms of erosion of atherosclerotic plaques | 4.0 | 154 | Citations (PDF) |
| 242 | Fundamental Cardiovascular Research: Returns on Societal Investment: A Scientific Statement From the American Heart Association | 13.1 | 6 | Citations (PDF) |
| 243 | Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial | 2.2 | 110 | Citations (PDF) |
| 244 | More than an anticoagulant: Do heparins have direct anti-inflammatory effects? | 4.1 | 183 | Citations (PDF) |
| 245 | Featuring: Dr Peter Libby | 2.3 | 0 | Citations (PDF) |
| 246 | Inflammation and thrombosis – testing the hypothesis with anti- inflammatory drug trials | 4.1 | 54 | Citations (PDF) |
| 247 | Mechanisms of Myeloid Cell Modulation of Atherosclerosis | 3.5 | 40 | Citations (PDF) |
| 248 | The “Intermediate” CD14++CD16+ monocyte subset increases in severe peripheral artery disease in humans | 3.4 | 107 | Citations (PDF) |
| 249 | Point-of-Care Technologies for Precision Cardiovascular Care and Clinical Research | 3.3 | 49 | Citations (PDF) |
| 250 | Targeted Near-Infrared Fluorescence Imaging of Atherosclerosis | 6.1 | 117 | Citations (PDF) |
| 251 | Early atheroprotection by SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progression | 1.5 | 0 | Citations (PDF) |
| 252 | Increased intermediate CD14++CD16++ monocyte subset levels associate with restenosis after peripheral percutaneous transluminal angioplasty | 1.5 | 26 | Citations (PDF) |
| 253 | Proliferation and Recruitment Contribute to Myocardial Macrophage Expansion in Chronic Heart Failure | 13.1 | 406 | Citations (PDF) |
| 254 | Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis | 34.5 | 760 | Citations (PDF) |
| 255 | RNAi targeting multiple cell adhesion molecules reduces immune cell recruitment and vascular inflammation after myocardial infarction | 12.5 | 205 | Citations (PDF) |
| 256 | Genesis and growth of extracellular-vesicle-derived microcalcification in atherosclerotic plaques | 33.4 | 386 | Citations (PDF) |
| 257 | Asthma Associates With Human Abdominal Aortic Aneurysm and Rupture | 6.0 | 28 | Citations (PDF) |
| 258 | Atheroprotection through SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progression | 7.0 | 37 | Citations (PDF) |
| 259 | Allergic lung inflammation promotes atherosclerosis in apolipoprotein E-deficient mice | 4.0 | 18 | Citations (PDF) |
| 260 | Leukocytes Link Local and Systemic Inflammation in Ischemic Cardiovascular Disease | 2.3 | 323 | Citations (PDF) |
| 261 | Allergic Lung Inflammation Aggravates Angiotensin II–Induced Abdominal Aortic Aneurysms in Mice | 6.0 | 36 | Citations (PDF) |
| 262 | Temporal shifts in clinical presentation and underlying mechanisms of atherosclerotic disease | 35.5 | 161 | Citations (PDF) |
| 263 | Sortilin mediates vascular calcification via its recruitment into extracellular vesicles | 10.6 | 242 | Citations (PDF) |
| 264 | Redundancy of IL-1 Isoform Signaling and Its Implications for Arterial Remodeling | 2.3 | 27 | Citations (PDF) |
| 265 | Statins Improve the Resolution of Established Murine Venous Thrombosis: Reductions in Thrombus Burden and Vein Wall Scarring | 2.3 | 62 | Citations (PDF) |
| 266 | EP4 Receptor–Associated Protein in Macrophages Ameliorates Colitis and Colitis-Associated Tumorigenesis | 3.2 | 25 | Citations (PDF) |
| 267 | TLR2 and neutrophils potentiate endothelial stress, apoptosis and detachment: implications for superficial erosion | 2.2 | 346 | Citations (PDF) |
| 268 | ALX-chemy: adding spice to the inflammatory soup of atherosclerosis | 5.5 | 5 | Citations (PDF) |
| 269 | Oxidative Stress Biomarkers and Incidence of Postoperative Atrial Fibrillation in the Omega‐3 Fatty Acids for Prevention of Postoperative Atrial Fibrillation (OPERA) Trial | 4.0 | 55 | Citations (PDF) |
| 270 | In Vivo Nanoparticle Assessment of Pathological Endothelium Predicts the Development of Inflow Stenosis in Murine Arteriovenous Fistula | 6.0 | 12 | Citations (PDF) |
| 271 | Inflammation and plaque vulnerability | 7.3 | 744 | Citations (PDF) |
| 272 | Imaging Granzyme B Activity Assesses Immune-Mediated Myocarditis | 13.1 | 38 | Citations (PDF) |
| 273 | Murine “Model” Monotheism | 13.1 | 58 | Citations (PDF) |
| 274 | Selective Cathepsin S Inhibition Attenuates Atherosclerosis in Apolipoprotein E–Deficient Mice with Chronic Renal Disease | 3.4 | 73 | Citations (PDF) |
| 275 | How does lipid lowering prevent coronary events? New insights from human imaging trials | 2.2 | 47 | Citations (PDF) |
| 276 | Inflammation and Immunity in Diseases of the Arterial Tree | 13.1 | 353 | Citations (PDF) |
| 277 | Cathepsin G deficiency reduces periaortic calcium chloride injury-induced abdominal aortic aneurysms in mice | 1.8 | 22 | Citations (PDF) |
| 278 | Interleukin 18 function in atherosclerosis is mediated by the interleukin 18 receptor and the Na-Cl co-transporter | 33.0 | 99 | Citations (PDF) |
| 279 | Fanning the flames: inflammation in cardiovascular diseases | 5.5 | 25 | Citations (PDF) |
| 280 | Cardiovascular Drug Development | 2.3 | 199 | Citations (PDF) |
| 281 | Triglycerides on the rise: should we swap seats on the seesaw? | 2.2 | 77 | Citations (PDF) |
| 282 | Myocardial Infarction Activates CCR2+ Hematopoietic Stem and Progenitor Cells | 16.4 | 213 | Citations (PDF) |
| 283 | Macrophages retain hematopoietic stem cells in the spleen via VCAM-1 | 9.3 | 174 | Citations (PDF) |
| 284 | Activation of prostaglandin E2-EP4 signaling reduces chemokine production in adipose tissue | 3.6 | 26 | Citations (PDF) |
| 285 | Imaging Macrophage and Hematopoietic Progenitor Proliferation in Atherosclerosis | 13.1 | 83 | Citations (PDF) |
| 286 | Leptin Deficiency Shifts Mast Cells toward Anti-Inflammatory Actions and Protects Mice from Obesity and Diabetes by Polarizing M2 Macrophages | 25.2 | 130 | Citations (PDF) |
| 287 | Deficiency of FcϵR1 Increases Body Weight Gain but Improves Glucose Tolerance in Diet-Induced Obese Mice | 2.5 | 6 | Citations (PDF) |
| 288 | Lp-PLA
2
Antagonizes Left Ventricular Healing After Myocardial Infarction by Impairing the Appearance of Reparative Macrophages | 4.4 | 13 | Citations (PDF) |
| 289 | Angiotensin II-induced TLR4 mediated abdominal aortic aneurysm in apolipoprotein E knockout mice is dependent on STAT3 | 3.8 | 76 | Citations (PDF) |
| 290 | Targeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial Infarction | 18.0 | 242 | Citations (PDF) |
| 291 | Biomarkers | 6.0 | 17 | Citations (PDF) |
| 292 | Regulatory T cells in human and angiotensin II-induced mouse abdominal aortic aneurysms | 5.5 | 65 | Citations (PDF) |
| 293 | Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions | 2.2 | 387 | Citations (PDF) |
| 294 | Silencing of CCR2 in myocarditis | 2.2 | 139 | Citations (PDF) |
| 295 | Self-renewing resident arterial macrophages arise from embryonic CX3CR1+ precursors and circulating monocytes immediately after birth | 23.5 | 348 | Citations (PDF) |
| 296 | Ly-6C
high
Monocytes Depend on Nr4a1 to Balance Both Inflammatory and Reparative Phases in the Infarcted Myocardium | 13.1 | 541 | Citations (PDF) |
| 297 | Increased Microvascularization and Vessel Permeability Associate With Active Inflammation in Human Atheromata | 2.9 | 78 | Citations (PDF) |
| 298 | Matrix Metalloproteinase-13 Predominates Over Matrix Metalloproteinase-8 as the Functional Interstitial Collagenase in Mouse Atheromata | 6.0 | 51 | Citations (PDF) |
| 299 | CXCR3 Controls T-Cell Accumulation in Fat Inflammation | 6.0 | 30 | Citations (PDF) |
| 300 | Non-coronary atherosclerosis | 2.2 | 171 | Citations (PDF) |
| 301 | Cardiovascular remodelling in coronary artery disease and heart failure | 62.1 | 691 | Citations (PDF) |
| 302 | Innate Response Activator B Cells Aggravate Atherosclerosis by Stimulating T Helper-1 Adaptive Immunity | 18.0 | 127 | Citations (PDF) |
| 303 | Coinhibitory Suppression of T Cell Activation by CD40 Protects Against Obesity and Adipose Tissue Inflammation in Mice | 18.0 | 63 | Citations (PDF) |
| 304 | Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN | 1.4 | 159 | Citations (PDF) |
| 305 | Cathepsin G activity lowers plasma LDL and reduces atherosclerosis | 4.1 | 45 | Citations (PDF) |
| 306 | High-Intensity Statin Therapy Alters the Natural History of Diabetic Coronary Atherosclerosis: Insights From SATURN | 6.2 | 56 | Citations (PDF) |
| 307 | Sex-Related Differences of Coronary Atherosclerosis Regression Following Maximally Intensive Statin Therapy | 6.1 | 56 | Citations (PDF) |
| 308 | Moderate Hypoxia Potentiates Interleukin-1β Production in Activated Human Macrophages | 13.1 | 141 | Citations (PDF) |
| 309 | Antiatherosclerotic Effects of Long-Term Maximally Intensive Statin Therapy After Acute Coronary Syndrome | 6.0 | 48 | Citations (PDF) |
| 310 | Chronic variable stress activates hematopoietic stem cells | 33.0 | 745 | Citations (PDF) |
| 311 | In Vivo Silencing of the Transcription Factor IRF5 Reprograms the Macrophage Phenotype and Improves Infarct Healing | 2.3 | 259 | Citations (PDF) |
| 312 | Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development | 3.8 | 253 | Citations (PDF) |
| 313 | Inflammation and its Resolution as Determinants of Acute Coronary Syndromes | 13.1 | 496 | Citations (PDF) |
| 314 | Plasma Pentraxin 3 Levels Do Not Predict Coronary Events but Reflect Metabolic Disorders in Patients with Coronary Artery Disease in the CARE Trial | 2.3 | 16 | Citations (PDF) |
| 315 | Monocyte heterogeneity in cardiovascular disease | 8.1 | 84 | Citations (PDF) |
| 316 | Local proliferation dominates lesional macrophage accumulation in atherosclerosis | 33.0 | 988 | Citations (PDF) |
| 317 | Rationale and design of the Cardiovascular Inflammation Reduction Trial: A test of the inflammatory hypothesis of atherothrombosis | 2.9 | 361 | Citations (PDF) |
| 318 | Adiponectin inhibits macrophage tissue factor, a key trigger of thrombosis in disrupted atherosclerotic plaques | 1.5 | 22 | Citations (PDF) |
| 319 | Mechanisms of Acute Coronary Syndromes and Their Implications for Therapy | 34.5 | 1,115 | Citations (PDF) |
| 320 | Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans | 22.6 | 636 | Citations (PDF) |
| 321 | Polymeric Nanoparticle PET/MR Imaging Allows Macrophage Detection in Atherosclerotic Plaques | 13.1 | 152 | Citations (PDF) |
| 322 | Factors underlying regression of coronary atheroma with potent statin therapy | 2.2 | 73 | Citations (PDF) |
| 323 | Cathepsin S-mediated fibroblast trans-differentiation contributes to left ventricular remodelling after myocardial infarction | 5.5 | 58 | Citations (PDF) |
| 324 | Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy | 2.2 | 94 | Citations (PDF) |
| 325 | Mechanisms of Acute Coronary Syndromes | 34.5 | 66 | Citations (PDF) |
| 326 | Vasospasm of Atherosclerotic Coronary Arteries Precipitates Acute Ischemic Myocardial Damage in Myocardial Infarction–Prone Strain of the Watanabe Heritable Hyperlipidemic Rabbits | 6.0 | 36 | Citations (PDF) |
| 327 | Inflammatory Biomarkers, Death, and Recurrent Nonfatal Coronary Events After an Acute Coronary Syndrome in the MIRACL Study | 4.0 | 77 | Citations (PDF) |
| 328 | Nanoparticle PET-CT Detects Rejection and Immunomodulation in Cardiac Allografts | 2.9 | 43 | Citations (PDF) |
| 329 | Macrophage-Derived Matrix Vesicles | 13.1 | 501 | Citations (PDF) |
| 330 | Thin-Capped Atheromata With Reduced Collagen Content in Pigs Develop in Coronary Arterial Regions Exposed to Persistently Low Endothelial Shear Stress | 6.0 | 99 | Citations (PDF) |
| 331 | C-Reactive Protein, but not Low-Density Lipoprotein Cholesterol Levels, Associate With Coronary Atheroma Regression and Cardiovascular Events After Maximally Intensive Statin Therapy | 18.0 | 118 | Citations (PDF) |
| 332 | Collagenases and cracks in the plaque | 10.6 | 106 | Citations (PDF) |
| 333 | New Insights into Plaque Stabilisation by Lipid Lowering | 11.4 | 25 | Citations (PDF) |
| 334 | Cathepsin K Deficiency Reduces Elastase Perfusion–Induced Abdominal Aortic Aneurysms in Mice | 6.0 | 96 | Citations (PDF) |
| 335 | Fish Oil and Postoperative Atrial Fibrillation | 16.5 | 220 | Citations (PDF) |
| 336 | Adiponectin Induces Pro-inflammatory Programs in Human Macrophages and CD4+ T Cells | 2.2 | 122 | Citations (PDF) |
| 337 | Non-invasive anatomic and functional imaging of vascular inflammation and unstable plaque | 2.2 | 101 | Citations (PDF) |
| 338 | Extramedullary Hematopoiesis Generates Ly-6C
high
Monocytes That Infiltrate Atherosclerotic Lesions | 18.0 | 460 | Citations (PDF) |
| 339 | Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis | 9.3 | 518 | Citations (PDF) |
| 340 | Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial | 62.1 | 778 | Citations (PDF) |
| 341 | Myocardial infarction accelerates atherosclerosis | 37.9 | 1,017 | Citations (PDF) |
| 342 | Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen | 18.0 | 539 | Citations (PDF) |
| 343 | “In vivo” imaging of atherosclerosis | 1.5 | 59 | Citations (PDF) |
| 344 | Molecular Imaging of Atherosclerosis for Improving Diagnostic and Therapeutic Development | 13.1 | 117 | Citations (PDF) |
| 345 | Relationship of antihypertensive treatment to plasma markers of vascular inflammation and remodeling in the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis study | 2.9 | 11 | Citations (PDF) |
| 346 | A guanidine‐rich regulatory oligodeoxynucleotide improves type‐2 diabetes in obese mice by blocking T‐cell differentiation | 7.1 | 13 | Citations (PDF) |
| 347 | Inflammation in Atherosclerosis | 6.0 | 2,098 | Citations (PDF) |
| 348 | Two-Dimensional Intravascular Near-Infrared Fluorescence Molecular Imaging of Inflammation in Atherosclerosis and Stent-Induced Vascular Injury | 2.3 | 164 | Citations (PDF) |
| 349 | Hypoxia But Not Inflammation Augments Glucose Uptake in Human Macrophages | 2.3 | 311 | Citations (PDF) |
| 350 | Effect of Two Intensive Statin Regimens on Progression of Coronary Disease | 34.5 | 852 | Citations (PDF) |
| 351 | The ω-3 fatty acids for Prevention of Post-Operative Atrial Fibrillation trial—rationale and design | 2.9 | 33 | Citations (PDF) |
| 352 | Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) | 2.9 | 780 | Citations (PDF) |
| 353 | Liberation of desmosine and isodesmosine as amino acids from insoluble elastin by elastolytic proteases | 2.1 | 35 | Citations (PDF) |
| 354 | Therapeutic siRNA silencing in inflammatory monocytes in mice | 29.8 | 786 | Citations (PDF) |
| 355 | Impact of statins on progression of atherosclerosis: rationale and design of SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: Effect of Rosuvastatin versus AtorvastatiN) | 2.1 | 45 | Citations (PDF) |
| 356 | Molecular imaging of macrophage protease activity in cardiovascular inflammation in vivo | 4.1 | 63 | Citations (PDF) |
| 357 | Highlights of 10 years of immunology in Nature Reviews Immunology | 53.8 | 102 | Citations (PDF) |
| 358 | Progress and challenges in translating the biology of atherosclerosis | 37.9 | 3,571 | Citations (PDF) |
| 359 | Report of the National Heart, Lung, and Blood Institute Working Group on the Translation of Cardiovascular Molecular Imaging | 18.0 | 48 | Citations (PDF) |
| 360 | Indocyanine Green Enables Near-Infrared Fluorescence Imaging of Lipid-Rich, Inflamed Atherosclerotic Plaques | 12.5 | 210 | Citations (PDF) |
| 361 | Augmented Expression and Activity of Extracellular Matrix-Degrading Enzymes in Regions of Low Endothelial Shear Stress Colocalize With Coronary Atheromata With Thin Fibrous Caps in Pigs | 18.0 | 153 | Citations (PDF) |
| 362 | Deletion of EP4 on Bone Marrow–Derived Cells Enhances Inflammation and Angiotensin II–Induced Abdominal Aortic Aneurysm Formation | 6.0 | 62 | Citations (PDF) |
| 363 | Lack of EP4 receptors on bone marrow-derived cells enhances inflammation in atherosclerotic lesions | 5.5 | 41 | Citations (PDF) |
| 364 | Binding of CD40L to Mac-1's I-Domain Involves the EQLKKSKTL Motif and Mediates Leukocyte Recruitment and Atherosclerosis—But Does Not Affect Immunity and Thrombosis in Mice | 13.1 | 103 | Citations (PDF) |
| 365 | Cathepsin L Activity Is Essential to Elastase Perfusion–Induced Abdominal Aortic Aneurysms in Mice | 6.0 | 78 | Citations (PDF) |
| 366 | Mast Cell Tryptase Deficiency Attenuates Mouse Abdominal Aortic Aneurysm Formation | 13.1 | 78 | Citations (PDF) |
| 367 | Selective Inhibition of Matrix Metalloproteinase-13 Increases Collagen Content of Established Mouse Atherosclerosis | 6.0 | 128 | Citations (PDF) |
| 368 | Loss of Myeloid Related Protein-8/14 Exacerbates Cardiac Allograft Rejection | 18.0 | 37 | Citations (PDF) |
| 369 | IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe–/– mice | 10.6 | 169 | Citations (PDF) |
| 370 | Clinical implications of inflammation for cardiovascular primary prevention | 2.2 | 86 | Citations (PDF) |
| 371 | CD40L induces inflammation and adipogenesis in adipose cells – a potential link between metabolic and cardiovascular disease | 4.1 | 66 | Citations (PDF) |
| 372 | Advances in Imaging of Cardiac Allograft Rejection | 0.6 | 5 | Citations (PDF) |
| 373 | Relation of Baseline High-Sensitivity C-Reactive Protein Level to Cardiovascular Outcomes With Rosuvastatin in the Justification for Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) | 1.8 | 147 | Citations (PDF) |
| 374 | Adaptive immunity and atherosclerosis | 2.6 | 263 | Citations (PDF) |
| 375 | How Our Growing Understanding of Inflammation Has Reshaped the Way We Think of Disease and Drug Development | 4.7 | 8 | Citations (PDF) |
| 376 | Response to Letter Regarding Article, “CC Chemokine Receptor-1 Activates Intimal Smooth Muscle–Like Cells in Graft Arterial Disease” | 18.0 | 0 | Citations (PDF) |
| 377 | Tumor Necrosis Factor Receptor–Associated Factor 1 (TRAF1) Deficiency Attenuates Atherosclerosis in Mice by Impairing Monocyte Recruitment to the Vessel Wall | 18.0 | 68 | Citations (PDF) |
| 378 | Spatiotemporal controlled delivery of nanoparticles to injured vasculature | 7.5 | 249 | Citations (PDF) |
| 379 | High-Resolution Magnetic Resonance Imaging Enhanced With Superparamagnetic Nanoparticles Measures Macrophage Burden in Atherosclerosis | 18.0 | 168 | Citations (PDF) |
| 380 | Deficiency of Antigen-Presenting Cell Invariant Chain Reduces Atherosclerosis in Mice | 18.0 | 83 | Citations (PDF) |
| 381 | Identifying Patients at High Risk of a Cardiovascular Event in the Near Future | 18.0 | 83 | Citations (PDF) |
| 382 | Stirring the soup of innate immunity in the acute coronary syndromes | 2.2 | 6 | Citations (PDF) |
| 383 | Increased Glucose Uptake in Visceral Versus Subcutaneous Adipose Tissue Revealed by PET Imaging | 6.1 | 110 | Citations (PDF) |
| 384 | HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial | 62.1 | 233 | Citations (PDF) |
| 385 | Impaired Infarct Healing in Atherosclerotic Mice With Ly-6ChiMonocytosis | 2.3 | 310 | Citations (PDF) |
| 386 | Cystatin C Deficiency Promotes Inflammation in Angiotensin II–Induced Abdominal Aortic Aneurisms in Atherosclerotic Mice | 3.4 | 55 | Citations (PDF) |
| 387 | Loss of MRP-14 Augments Costimulatory molecule Expression and Exacerbates Cardiac Allograft Rejection (145.47) | 0.6 | 0 | Citations (PDF) |
| 388 | Number Needed to Treat With Rosuvastatin to Prevent First Cardiovascular Events and Death Among Men and Women With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein | 4.1 | 138 | Citations (PDF) |
| 389 | A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism | 34.5 | 712 | Citations (PDF) |
| 390 | Kruppel-like Factor KLF10 Targets Transforming Growth Factor-β1 to Regulate CD4+CD25− T Cells and T Regulatory Cells | 2.2 | 96 | Citations (PDF) |
| 391 | Arterial and Aortic Valve Calcification Abolished by Elastolytic Cathepsin S Deficiency in Chronic Renal Disease | 18.0 | 290 | Citations (PDF) |
| 392 | Adiponectin Inhibits Pro-inflammatory Signaling in Human Macrophages Independent of Interleukin-10 | 2.2 | 132 | Citations (PDF) |
| 393 | Optical and Multimodality Molecular Imaging | 6.0 | 182 | Citations (PDF) |
| 394 | Molecular Imaging of Innate Immune Cell Function in Transplant Rejection | 18.0 | 88 | Citations (PDF) |
| 395 | Myeloid-Related Protein-8/14 Is Critical for the Biological Response to Vascular Injury | 18.0 | 244 | Citations (PDF) |
| 396 | Critical Role of Mast Cell Chymase in Mouse Abdominal Aortic Aneurysm Formation | 18.0 | 140 | Citations (PDF) |
| 397 | Adiponectin Deficiency Increases Allergic Airway Inflammation and Pulmonary Vascular Remodeling | 3.8 | 191 | Citations (PDF) |
| 398 | Free Cholesterol Accumulation in Macrophage Membranes Activates Toll-Like Receptors and p38 Mitogen-Activated Protein Kinase and Induces Cathepsin K | 13.1 | 182 | Citations (PDF) |
| 399 | CC Chemokine Receptor-1 Activates Intimal Smooth Muscle–Like Cells in Graft Arterial Disease | 18.0 | 19 | Citations (PDF) |
| 400 | Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein Cholesterol Levels With Rosuvastatin 40 mg Daily (from the ASTEROID Study) | 1.8 | 22 | Citations (PDF) |
| 401 | The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: Periodontitis and Atherosclerotic Cardiovascular Disease††Published simultaneously in the Journal of Periodontology, the Official Journal of the American Academy of Periodontology. | 1.8 | 204 | Citations (PDF) |
| 402 | Innate and adaptive immunity in atherosclerosis | 8.1 | 163 | Citations (PDF) |
| 403 | Genetically engineered resistance for MMP collagenases promotes abdominal aortic aneurysm formation in mice infused with angiotensin II | 3.2 | 56 | Citations (PDF) |
| 404 | Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice | 33.0 | 716 | Citations (PDF) |
| 405 | Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis | 2.9 | 120 | Citations (PDF) |
| 406 | Relationship of Oxidized Phospholipids and Biomarkers of Oxidized Low-Density Lipoprotein With Cardiovascular Risk Factors, Inflammatory Biomarkers, and Effect of Statin Therapy in Patients With Acute Coronary Syndromes | 2.3 | 105 | Citations (PDF) |
| 407 | 18F-4V for PET–CT Imaging of VCAM-1 Expression in Atherosclerosis | 6.1 | 206 | Citations (PDF) |
| 408 | Obesity, inflammation, and atherosclerosis | 35.5 | 888 | Citations (PDF) |
| 409 | Endogenous tissue plasminogen activator and risk of recurrent cardiac events after an acute coronary syndrome in the MIRACL study | 1.5 | 21 | Citations (PDF) |
| 410 | T-Cell Activation Leads to Reduced Collagen Maturation in Atherosclerotic Plaques of Apoe−/− Mice | 3.4 | 50 | Citations (PDF) |
| 411 | Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial | 62.1 | 950 | Citations (PDF) |
| 412 | Inflammation in Atherosclerosis | 2.3 | 2,068 | Citations (PDF) |
| 413 | Reduction in C-Reactive Protein and Low-Density Lipoprotein Cholesterol and Cardiovascular Event Rates After Initiation of Rosuvastatin: A Prospective Study of the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin Trial | 0.5 | 0 | Citations (PDF) |
| 414 | Adiponectin Inhibits Allograft Rejection in Murine Cardiac Transplantation | 2.1 | 41 | Citations (PDF) |
| 415 | Monocyte Subset Dynamics in Human Atherosclerosis Can Be Profiled with Magnetic Nano-Sensors | 2.3 | 53 | Citations (PDF) |
| 416 | The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models | 53.8 | 741 | Citations (PDF) |
| 417 | The molecular mechanisms of the thrombotic complications of atherosclerosis | 7.3 | 196 | Citations (PDF) |
| 418 | The Multiple Facets of the Fat Tissue | 4.4 | 46 | Citations (PDF) |
| 419 | Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein | 34.5 | 6,358 | Citations (PDF) |
| 420 | Nanoparticle PET-CT Imaging of Macrophages in Inflammatory Atherosclerosis | 18.0 | 543 | Citations (PDF) |
| 421 | Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Theraphy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial | 2.9 | 163 | Citations (PDF) |
| 422 | Genetically Programmed Biases in Th1 and Th2 Immune Responses Modulate Atherogenesis | 3.4 | 170 | Citations (PDF) |
| 423 | Improved characterization of atherosclerotic plaques by gadolinium contrast during intravascular magnetic resonance imaging of human arteries | 1.5 | 40 | Citations (PDF) |
| 424 | Glycated LDL increases monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated chemotaxis | 1.5 | 51 | Citations (PDF) |
| 425 | Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction | 1.1 | 811 | Citations (PDF) |
| 426 | Prostaglandin E Receptor Type 4-associated Protein Interacts Directly with NF-κB1 and Attenuates Macrophage Activation | 2.2 | 87 | Citations (PDF) |
| 427 | CD11c
+
Dendritic Cells Maintain Antigen Processing, Presentation Capabilities, and CD4
+
T-Cell Priming Efficacy Under Hypercholesterolemic Conditions Associated With Atherosclerosis | 13.1 | 98 | Citations (PDF) |
| 428 | Leukocyte Integrin Mac-1 Promotes Acute Cardiac Allograft Rejection | 18.0 | 27 | Citations (PDF) |
| 429 | Inflammation, Statin Therapy, and Risk of Stroke After an Acute Coronary Syndrome in the MIRACL Study | 6.0 | 65 | Citations (PDF) |
| 430 | Plasma Concentration of Heat Shock Protein 27 and Risk of Cardiovascular Disease: A Prospective, Nested Case-Control Study | 1.1 | 40 | Citations (PDF) |
| 431 | Noninvasive In Vivo Imaging of Monocyte Trafficking to Atherosclerotic Lesions | 18.0 | 103 | Citations (PDF) |
| 432 | Interferon-γ, a Th1 Cytokine, Regulates Fat Inflammation | 13.1 | 490 | Citations (PDF) |
| 433 | Real-Time Catheter Molecular Sensing of Inflammation in Proteolytically Active Atherosclerosis | 18.0 | 200 | Citations (PDF) |
| 434 | Activatable Magnetic Resonance Imaging Agent Reports Myeloperoxidase Activity in Healing Infarcts and Noninvasively Detects the Antiinflammatory Effects of Atorvastatin on Ischemia-Reperfusion Injury | 18.0 | 185 | Citations (PDF) |
| 435 | Matrix Metalloproteinase-14 Deficiency in Bone Marrow–Derived Cells Promotes Collagen Accumulation in Mouse Atherosclerotic Plaques | 18.0 | 123 | Citations (PDF) |
| 436 | Adiponectin Inhibits the Production of CXC Receptor 3 Chemokine Ligands in Macrophages and Reduces T-Lymphocyte Recruitment in Atherogenesis | 13.1 | 193 | Citations (PDF) |
| 437 | TRAF-1 Deficient Mice Show Impaired Monocyte Recruitment and Decreased AtherogenesisBlood, 2008, 112, 696-696 | 4.8 | 1 | Citations (PDF) |
| 438 | Interleukin-18, the Metabolic Syndrome, and Subclinical Atherosclerosis | 6.0 | 103 | Citations (PDF) |
| 439 | CD40 Ligand Mediates Inflammation Independently of CD40 by Interaction With Mac-1 | 18.0 | 223 | Citations (PDF) |
| 440 | Increased Plasma Oxidized Phospholipid:Apolipoprotein B-100 Ratio With Concomitant Depletion of Oxidized Phospholipids From Atherosclerotic Lesions After Dietary Lipid-Lowering | 6.0 | 82 | Citations (PDF) |
| 441 | Vascular Remodeling in Transplant Vasculopathy | 13.1 | 254 | Citations (PDF) |
| 442 | TRAF-1, -2, -3, -5, and -6 Are Induced in Atherosclerotic Plaques and Differentially Mediate Proinflammatory Functions of CD40L in Endothelial Cells | 6.0 | 104 | Citations (PDF) |
| 443 | Apolipoprotein CIII-Induced THP-1 Cell Adhesion to Endothelial Cells Involves Pertussis Toxin-Sensitive G Protein- and Protein Kinase Cα-Mediated Nuclear Factor-κB Activation | 6.0 | 97 | Citations (PDF) |
| 444 | Optical Visualization of Cathepsin K Activity in Atherosclerosis With a Novel, Protease-Activatable Fluorescence Sensor | 18.0 | 254 | Citations (PDF) |
| 445 | Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata | 10.6 | 1,149 | Citations (PDF) |
| 446 | Cathepsin L Deficiency Reduces Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor–Knockout Mice | 18.0 | 129 | Citations (PDF) |
| 447 | Deletion of the phosphoinositide 3-kinase p110 gene attenuates murine atherosclerosis | 7.5 | 105 | Citations (PDF) |
| 448 | Response to Letter Regarding Article, “Platelet Expression Profiling and Clinical Validation of Myeloid-Related Protein-14 as a Novel Determinant of Cardiovascular Events” | 18.0 | 0 | Citations (PDF) |
| 449 | Intertwining of thrombosis and inflammation in atherosclerosis | 0.3 | 0 | Citations (PDF) |
| 450 | Intertwining of thrombosis and inflammation in atherosclerosis | 2.8 | 257 | Citations (PDF) |
| 451 | AGE-BSA decreases ABCG1 expression and reduces macrophage cholesterol efflux to HDL | 1.5 | 55 | Citations (PDF) |
| 452 | Molecular Imaging of Cardiovascular Disease | 18.0 | 212 | Citations (PDF) |
| 453 | The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions | 9.3 | 2,205 | Citations (PDF) |
| 454 | Atherosclerosis | 2.3 | 65 | Citations (PDF) |
| 455 | A Fluorescent Probe for the Detection of Myeloperoxidase Activity in Atherosclerosis-Associated Macrophages | 4.7 | 255 | Citations (PDF) |
| 456 | Cathepsin L activity controls adipogenesis and glucose tolerance | 16.3 | 147 | Citations (PDF) |
| 457 | Mast cells promote atherosclerosis by releasing proinflammatory cytokines | 33.0 | 397 | Citations (PDF) |
| 458 | The Inflammation Hypothesis and Its Potential Relevance to Statin Therapy | 1.8 | 111 | Citations (PDF) |
| 459 | Baseline Characteristics of Participants in the JUPITER Trial, A Randomized Placebo-Controlled Primary Prevention Trial of Statin Therapy Among Individuals With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein | 1.8 | 116 | Citations (PDF) |
| 460 | Are we victims of our own success in cardiovascular therapeutics? | 4.7 | 0 | Citations (PDF) |
| 461 | Inflammatory Mechanisms: The Molecular Basis of Inflammation and Disease | 5.6 | 381 | Citations (PDF) |
| 462 | Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice | 10.6 | 225 | Citations (PDF) |
| 463 | Inflammation in Atherosclerosis | 18.0 | 419 | Citations (PDF) |
| 464 | Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells | 1.5 | 204 | Citations (PDF) |
| 465 | Characterization of smooth muscle-like cells in circulating human peripheral blood | 1.5 | 83 | Citations (PDF) |
| 466 | C-Reactive Protein Induces Matrix Metalloproteinase-1 and -10 in Human Endothelial Cells | 2.3 | 180 | Citations (PDF) |
| 467 | Molecular and Cellular Imaging of Atherosclerosis | 2.3 | 198 | Citations (PDF) |
| 468 | Inflammation and Atherothrombosis | 2.3 | 170 | Citations (PDF) |
| 469 | The future of living well to 100– | 4.7 | 2 | Citations (PDF) |
| 470 | Adiponectin: a key adipocytokine in metabolic syndrome | 6.2 | 391 | Citations (PDF) |
| 471 | Influence of pre-analytical and analytical factors on soluble CD40L measurements | 6.2 | 55 | Citations (PDF) |
| 472 | Inflammation and cardiovascular disease mechanisms | 4.7 | 984 | Citations (PDF) |
| 473 | The immune response in atherosclerosis: a double-edged sword | 53.8 | 2,017 | Citations (PDF) |
| 474 | Plaque Stabilization: Can We Turn Theory into Evidence? | 1.8 | 60 | Citations (PDF) |
| 475 | Atherosclerosis and proteinase activation | 5.5 | 230 | Citations (PDF) |
| 476 | Vascular Biomarkers and Surrogates in Cardiovascular Disease | 18.0 | 154 | Citations (PDF) |
| 477 | A Novel Prostaglandin E Receptor 4–Associated Protein Participates in Antiinflammatory Signaling | 13.1 | 66 | Citations (PDF) |
| 478 | Apolipoprotein CIII in Apolipoprotein B Lipoproteins Enhances the Adhesion of Human Monocytic Cells to Endothelial Cells | 18.0 | 206 | Citations (PDF) |
| 479 | Platelet Expression Profiling and Clinical Validation of Myeloid-Related Protein-14 as a Novel Determinant of Cardiovascular Events | 18.0 | 331 | Citations (PDF) |
| 480 | Noninvasive Vascular Cell Adhesion Molecule-1 Imaging Identifies Inflammatory Activation of Cells in Atherosclerosis | 18.0 | 602 | Citations (PDF) |
| 481 | Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis | 16.5 | 1,896 | Citations (PDF) |
| 482 | Metformin Inhibits Proinflammatory Responses and Nuclear Factor-κB in Human Vascular Wall Cells | 6.0 | 484 | Citations (PDF) |
| 483 | Apolipoprotein CIII Induces Expression of Vascular Cell Adhesion Molecule-1 in Vascular Endothelial Cells and Increases Adhesion of Monocytic Cells | 18.0 | 282 | Citations (PDF) |
| 484 | Inflammation and Cellular Immune Responses in Abdominal Aortic Aneurysms | 6.0 | 600 | Citations (PDF) |
| 485 | Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease | 7.5 | 342 | Citations (PDF) |
| 486 | Local Cytokine Environments Drive Aneurysm Formation in Allografted Aortas | 7.2 | 26 | Citations (PDF) |
| 487 | CADASIL mutations impair Notch3 glycosylation by Fringe | 2.9 | 58 | Citations (PDF) |
| 488 | Atherogenesis in Mice Does Not Require CD40 Ligand From Bone Marrow–Derived Cells | 6.0 | 63 | Citations (PDF) |
| 489 | Characterization of Human Atherosclerotic Plaques by Intravascular Magnetic Resonance Imaging | 18.0 | 129 | Citations (PDF) |
| 490 | Angiotensin Type 2 Receptor Is Expressed in Murine Atherosclerotic Lesions and Modulates Lesion Evolution | 18.0 | 79 | Citations (PDF) |
| 491 | Elevated release of sCD40L from platelets of diabetic patients by thrombin, glucose and advanced glycation end products | 2.7 | 51 | Citations (PDF) |
| 492 | Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus | 18.0 | 248 | Citations (PDF) |
| 493 | Inhibition of Atherogenesis in BLT1-Deficient Mice Reveals a Role for LTB4 and BLT1 in Smooth Muscle Cell Recruitment | 18.0 | 135 | Citations (PDF) |
| 494 | Matrix Metalloproteinase-13/Collagenase-3 Deletion Promotes Collagen Accumulation and Organization in Mouse Atherosclerotic Plaques | 18.0 | 212 | Citations (PDF) |
| 495 | Associations Between Soluble CD40 Ligand, Atherosclerosis Risk Factors, and Subclinical Atherosclerosis | 6.0 | 95 | Citations (PDF) |
| 496 | Pathophysiology of Coronary Artery Disease | 18.0 | 1,737 | Citations (PDF) |
| 497 | Cystatin C Deficiency Increases Elastic Lamina Degradation and Aortic Dilatation in Apolipoprotein E–Null Mice | 13.1 | 146 | Citations (PDF) |
| 498 | The Forgotten Majority | 2.3 | 380 | Citations (PDF) |
| 499 | Lipid Lowering Therapy in Atherosclerosis | 3.2 | 27 | Citations (PDF) |
| 500 | B7-1/B7-2 Costimulation Regulates Plaque Antigen–Specific T-Cell Responses and Atherogenesis in Low-Density Lipoprotein Receptor–Deficient Mice | 18.0 | 141 | Citations (PDF) |
| 501 | Macrophage Migration Inhibitory Factor Deficiency Impairs Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice | 18.0 | 170 | Citations (PDF) |
| 502 | C-Peptide Colocalizes with Macrophages in Early Arteriosclerotic Lesions of Diabetic Subjects and Induces Monocyte Chemotaxis In Vitro | 6.0 | 110 | Citations (PDF) |
| 503 | Lysosomal Cysteine Proteases in Atherosclerosis | 6.0 | 360 | Citations (PDF) |
| 504 | Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure | 16.5 | 1,075 | Citations (PDF) |
| 505 | Atherosclerotic Vascular Disease Conference | 18.0 | 318 | Citations (PDF) |
| 506 | CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease | 18.0 | 98 | Citations (PDF) |
| 507 | Effect of Atorvastatin on Risk of Recurrent Cardiovascular Events After an Acute Coronary Syndrome Associated With High Soluble CD40 Ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study | 18.0 | 166 | Citations (PDF) |
| 508 | Essential Role for Smad3 in Regulating MCP-1 Expression and Vascular Inflammation | 13.1 | 95 | Citations (PDF) |
| 509 | Wild-type but not interferon-?-deficient T cells induce graft arterial disease in the absence of B cells | 5.5 | 9 | Citations (PDF) |
| 510 | Genetically Determined Resistance to Collagenase Action Augments Interstitial Collagen Accumulation in Atherosclerotic Plaques | 18.0 | 93 | Citations (PDF) |
| 511 | Inflammation, Immunity, and HMG-CoA Reductase Inhibitors | 18.0 | 445 | Citations (PDF) |
| 512 | Hypochlorous Acid, a Macrophage Product, Induces Endothelial Apoptosis and Tissue Factor Expression | 6.0 | 402 | Citations (PDF) |
| 513 | Enhanced Expression of CD44 Variants in Human Atheroma and Abdominal Aortic Aneurysm | 3.4 | 53 | Citations (PDF) |
| 514 | What happens inside an atherosclerotic plaque? | 0.2 | 1 | Citations (PDF) |
| 515 | Role of elastolytic cathepsins in vascular remodeling | 0.2 | 0 | Citations (PDF) |
| 516 | The vulnerable atherosclerotic plaque | 1.5 | 215 | Citations (PDF) |
| 517 | Th2-predominant inflammation and blockade of IFN-γ signaling induce aneurysms in allografted aortas | 10.6 | 113 | Citations (PDF) |
| 518 | Th2-predominant inflammation and blockade of IFN-γ signaling induce aneurysms in allografted aortas | 10.6 | 180 | Citations (PDF) |
| 519 | Effects of statins in reducing thrombotic risk and modulating plaque vulnerability | 2.0 | 45 | Citations (PDF) |
| 520 | Clinical trials report | 4.7 | 0 | Citations (PDF) |
| 521 | Tumor Necrosis Factor Receptor -1 and -2 Double Deficiency Reduces Graft Arterial Disease in Murine Cardiac Allografts | 4.5 | 42 | Citations (PDF) |
| 522 | Metformin and vascular protection: a cardiologist's view | 3.5 | 10 | Citations (PDF) |
| 523 | Macrophage migration inhibitory factor is associated with aneurysmal expansion | 1.8 | 61 | Citations (PDF) |
| 524 | From Vulnerable Plaque to Vulnerable Patient | 18.0 | 2,451 | Citations (PDF) |
| 525 | From Vulnerable Plaque to Vulnerable Patient | 18.0 | 1,605 | Citations (PDF) |
| 526 | Effect of a Cleavage-Resistant Collagen Mutation on Left Ventricular Remodeling | 13.1 | 36 | Citations (PDF) |
| 527 | Direct Anti-Inflammatory Mechanisms Contribute to Attenuation of Experimental Allograft Arteriosclerosis by Statins | 18.0 | 98 | Citations (PDF) |
| 528 | Soluble CD40L | 18.0 | 373 | Citations (PDF) |
| 529 | Elevated Plasma Levels of the Atherogenic Mediator Soluble CD40 Ligand in Diabetic Patients | 18.0 | 194 | Citations (PDF) |
| 530 | Neutrophil Elastase in Human Atherosclerotic Plaques | 18.0 | 226 | Citations (PDF) |
| 531 | High-Dose Atorvastatin Enhances the Decline in Inflammatory Markers in Patients With Acute Coronary Syndromes in the MIRACL Study | 18.0 | 397 | Citations (PDF) |
| 532 | Elastogenesis in Human Arterial Disease | 6.0 | 135 | Citations (PDF) |
| 533 | Soluble CD40 Ligand Levels Indicate Lipid Accumulation in Carotid Atheroma | 6.0 | 71 | Citations (PDF) |
| 534 | Deficiency of cathepsin S reduces atherosclerosis in LDL receptor–deficient mice | 10.6 | 165 | Citations (PDF) |
| 535 | Deficiency of cathepsin S reduces atherosclerosis in LDL receptor–deficient mice | 10.6 | 303 | Citations (PDF) |
| 536 | Thoughts on the Role of the Healing Professions and the Events of September 11, 2001 | 18.0 | 113 | Citations (PDF) |
| 537 | Cytokines Induce Indoleamine 2,3-Dioxygenase Expression in Human Atheroma-Associated Cells: Implications for Persistent Chlamydophila pneumoniae Infection | 2.7 | 62 | Citations (PDF) |
| 538 | Expression of Interleukin (IL)-18 and Functional IL-18 Receptor on Human Vascular Endothelial Cells, Smooth Muscle Cells, and Macrophages | 9.3 | 492 | Citations (PDF) |
| 539 | Statins Reduce Inflammation in Atheroma of Nonhuman Primates Independent of Effects on Serum Cholesterol | 6.0 | 219 | Citations (PDF) |
| 540 | Mucosal Administration of Heat Shock Protein-65 Decreases Atherosclerosis and Inflammation in Aortic Arch of Low-Density Lipoprotein Receptor-Deficient Mice | 18.0 | 256 | Citations (PDF) |
| 541 | Prostaglandin E2 Suppresses Chemokine Production in Human Macrophages through the EP4 Receptor | 2.2 | 314 | Citations (PDF) |
| 542 | Progression of Atheroma | 6.0 | 275 | Citations (PDF) |
| 543 | Chlamydia pneumoniae as an Emerging Risk Factor in Cardiovascular Disease | 16.5 | 253 | Citations (PDF) |
| 544 | Diabetes and Atherosclerosis | 16.5 | 2,421 | Citations (PDF) |
| 545 | PPAR Activators as Antiinflammatory Mediators in Human T Lymphocytes | 13.1 | 327 | Citations (PDF) |
| 546 | Oxidized Low-Density Lipoprotein Augments and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Limit CD40 and CD40L Expression in Human Vascular Cells | 18.0 | 160 | Citations (PDF) |
| 547 | Cytokines in the Pathogenesis of Atherosclerosis | 4.1 | 232 | Citations (PDF) |
| 548 | Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis | 13.1 | 933 | Citations (PDF) |
| 549 | TH2 Predominant Immune Responses Prevail in Human Abdominal Aortic Aneurysm | 3.4 | 194 | Citations (PDF) |
| 550 | Cold Ischemia Induces Isograft Arteriopathy, but Does Not Augment Allograft Arteriopathy in Non-Immunosuppressed Hosts | 3.4 | 32 | Citations (PDF) |
| 551 | Induction of Tissue Factor Expression in Human Endothelial Cells by CD40 Ligand Is Mediated via Activator Protein 1, Nuclear Factor κB, and Egr-1 | 2.2 | 124 | Citations (PDF) |
| 552 | Lipid Lowering Reduces Oxidative Stress and Endothelial Cell Activation in Rabbit Atheroma | 18.0 | 207 | Citations (PDF) |
| 553 | Comparison between Adventitial and Intimal Inflammation of Ruptured and Nonruptured Atherosclerotic Plaques in Human Coronary Arteries | 0.2 | 55 | Citations (PDF) |
| 554 | Clinical trials report | 4.7 | 1 | Citations (PDF) |
| 555 | Inflammation in atherosclerosis | 37.9 | 7,853 | Citations (PDF) |
| 556 | Stabilization of atherosclerotic plaques: New mechanisms and clinical targets | 33.0 | 552 | Citations (PDF) |
| 557 | Atherosclerosis: The New View | 0.1 | 224 | Citations (PDF) |
| 558 | Macrophage Myeloperoxidase Regulation by Granulocyte Macrophage Colony-Stimulating Factor in Human Atherosclerosis and Implications in Acute Coronary Syndromes | 3.4 | 665 | Citations (PDF) |
| 559 | Atheromas that cause fatal thrombosis are usually large and frequently accompanied by vessel enlargement | 1.5 | 31 | Citations (PDF) |
| 560 | Chronic Rejection | 22.6 | 401 | Citations (PDF) |
| 561 | Potential Infectious Etiologies of Atherosclerosis: A Multifactorial Perspective | 3.8 | 103 | Citations (PDF) |
| 562 | Endothelial function and coronary artery disease | 4.0 | 330 | Citations (PDF) |
| 563 | Title is missing! | 2.2 | 57 | Citations (PDF) |
| 564 | The CD40/CD154 receptor/ligand dyadRID="†"ID="†" Review | 5.5 | 698 | Citations (PDF) |
| 565 | Host bone-marrow cells are a source of donor intimal smooth- muscle–like cells in murine aortic transplant arteriopathy | 33.0 | 462 | Citations (PDF) |
| 566 | Managing the risk of atherosclerosis: the role of high-density lipoprotein | 1.8 | 147 | Citations (PDF) |
| 567 | Mechanical Strain Induces Specific Changes in the Synthesis and Organization of Proteoglycans by Vascular Smooth Muscle Cells | 2.2 | 164 | Citations (PDF) |
| 568 | Peroxisome Proliferator-Activated Receptors (PPARs) and Their Role in the Vessel Wall: Possible Mediators of Cardiovascular Risk? | 2.2 | 25 | Citations (PDF) |
| 569 | Vascular inflammation and activation: new targets for lipid lowering*1 | 0.1 | 5 | Citations (PDF) |
| 570 | Inflammation and Atherothrombosis | 4.0 | 93 | Citations (PDF) |
| 571 | Ligation of CD40 on Vascular Smooth Muscle Cells Mediates Loss of Interstitial Collagen via Matrix Metalloproteinase Activity | 4.0 | 27 | Citations (PDF) |
| 572 | Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis | 10.6 | 209 | Citations (PDF) |
| 573 | Fatty acid modulation of endothelial activation | 4.7 | 417 | Citations (PDF) |
| 574 | EXPRESSION OF THROMBOSPONDIN AND RECEPTORS IN HUMAN CARDIAC ALLOGRAFTS AND ITS DIFFERENTIAL REGULATION IN EC AND SMC BY CYTOKINES. | 2.1 | 0 | Citations (PDF) |
| 575 | REGULATION OF iNOS EXPRESSION AND MYOCARDIAL CELL DEATH; MECHANISMS OF ALLOGRAFT SURVIVAL WITH CD40 LIGAND DEFICIENCY. | 2.1 | 0 | Citations (PDF) |
| 576 | Changing concepts of atherogenesis | 7.3 | 554 | Citations (PDF) |
| 577 | The acute coronary syndromes: have our tools constrained our thinking? | 0.0 | 4 | Citations (PDF) |
| 578 | Multiple Mechanisms of Thrombosis Complicating Atherosclerotic Plaques | 2.0 | 32 | Citations (PDF) |
| 579 | Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice | 7.5 | 328 | Citations (PDF) |
| 580 | Collaborative Multidisciplinary Workshop Report: Interface of Lipid Metabolism, Atherosclerosis, andChlamydiaInfection | 3.7 | 10 | Citations (PDF) |
| 581 | The Serpin Proteinase Inhibitor 9 Is an Endogenous Inhibitor of Interleukin 1β–Converting Enzyme (Caspase-1) Activity in Human Vascular Smooth Muscle Cells | 9.3 | 127 | Citations (PDF) |
| 582 | Association of B7-1 Co-Stimulation with the Development of Graft Arterial Disease | 3.4 | 42 | Citations (PDF) |
| 583 | CD40 Ligation Induces Tissue Factor Expression in Human Vascular Smooth Muscle Cells | 3.4 | 147 | Citations (PDF) |
| 584 | CD154 (CD40 ligand) | 2.6 | 93 | Citations (PDF) |
| 585 | Cholesterol and atherosclerosis | 2.4 | 127 | Citations (PDF) |
| 586 | Overview of the biologic determinants of plaque instability | 1.8 | 0 | Citations (PDF) |
| 587 | Stromelysin-1 (MMP-3) expression driven by a macrophage-specific promoter results in reduced viability in transgenic mice | 1.5 | 3 | Citations (PDF) |
| 588 | Lipid Lowering Reduces Proteolytic and Prothrombotic Potential in Rabbit Atheromaa | 4.0 | 40 | Citations (PDF) |
| 589 | Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction | 10.6 | 761 | Citations (PDF) |
| 590 | 10.1016/b978-0-323-63600-1.00006-5 | 0.0 | 0 | Citations (PDF) |
| 591 | 10.1016/b978-0-323-63600-1.09988-9 | 0.0 | 0 | Citations (PDF) |
| 592 | 10.1016/b978-84-8086-956-0.00061-7 | 0.0 | 0 | Citations (PDF) |
| 593 | 10.1016/b978-84-8086-956-0.00049-6 | 0.0 | 0 | Citations (PDF) |
| 594 | 10.1016/b978-84-8086-956-0.00043-5 | 0.0 | 0 | Citations (PDF) |
| 595 | 10.1016/b978-84-8086-956-0.00097-6 | 0.0 | 0 | Citations (PDF) |
| 596 | 10.1016/b978-84-8086-956-0.00023-x | 0.0 | 0 | Citations (PDF) |
| 597 | 10.1016/b978-84-8086-956-0.00047-2 | 0.0 | 0 | Citations (PDF) |
| 598 | 10.1016/b978-84-8086-956-0.00101-5 | 0.0 | 0 | Citations (PDF) |
| 599 | 10.1016/b978-84-8086-956-0.00044-7 | 0.0 | 0 | Citations (PDF) |
| 600 | Regulation of the Thrombotic Potential of Atheroma | 4.1 | 31 | Citations (PDF) |
| 601 | PPARγ Activation in Human Endothelial Cells Increases Plasminogen Activator Inhibitor Type-1 Expression | 6.0 | 363 | Citations (PDF) |
| 602 | Inflammatory Cytokines and Oxidized Low Density Lipoproteins Increase Endothelial Cell Expression of Membrane Type 1-Matrix Metalloproteinase | 2.2 | 187 | Citations (PDF) |
| 603 | Title is missing! | 2.1 | 14 | Citations (PDF) |
| 604 | The inhibition of endothelial activation by unsaturated fatty acids | 1.3 | 34 | Citations (PDF) |
| 605 | Expression of Stromelysin-3 in Atherosclerotic Lesions: Regulation via CD40–CD40 Ligand Signaling In Vitro and In Vivo | 9.3 | 159 | Citations (PDF) |
| 606 | Echocardiography-derived left ventricular end-systolic regional wall stress and matrix remodeling after experimental myocardial infarction | 2.3 | 50 | Citations (PDF) |
| 607 | Deficiencies of IL-4 or TNF-α receptor-1 do not diminish graft arteriosclerosis in cardiac allografts | 0.7 | 8 | Citations (PDF) |
| 608 | Molecular mediators of arterial inflammation: A role for microbial products? | 2.9 | 30 | Citations (PDF) |
| 609 | CD1 Expression in Human Atherosclerosis | 3.4 | 129 | Citations (PDF) |
| 610 | Augmented Expression of Cyclooxygenase-2 in Human Atherosclerotic Lesions | 3.4 | 378 | Citations (PDF) |
| 611 | T Lymphocytes Induce Endothelial Cell Matrix Metalloproteinase Expression by a CD40L-Dependent Mechanism | 3.4 | 172 | Citations (PDF) |
| 612 | Interleukin-10 (IL-10) Augments Allograft Arterial Disease | 3.4 | 74 | Citations (PDF) |
| 613 | HISTOLOGICAL EVIDENCE OF CONCOMITANT INTRAMYOCARDIAL AND EPICARDIAL VASCULITIS IN NECROPSIED HEART ALLOGRAFTS | 2.1 | 20 | Citations (PDF) |
| 614 | Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages | 10.6 | 462 | Citations (PDF) |
| 615 | Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells | 10.6 | 404 | Citations (PDF) |
| 616 | Cystatin C deficiency in human atherosclerosis and aortic aneurysms | 10.6 | 411 | Citations (PDF) |
| 617 | HEART TRANSPLANTATION USING MICE LACKING B7-1 AND B7-2 DEMONSTRATES THAT GRAFT SURVIVAL IS DETERMINED BY EXPRESSION OF B7 MOLECULES ON RECIPIENT, NOT DONOR CELLS. | 2.1 | 0 | Citations (PDF) |
| 618 | ACUTELY REJECTED MURINE CARDIAC ALLOGRAFTS IN IFN-γ DEFICIENT RECIPIENTS SHOW INCREASED MACROPHAGE INFILTRATION, ELEVATED MIP-2, AND MARKEDLY DECREASED RANTES EXPRESSION | 2.1 | 0 | Citations (PDF) |
| 619 | TH2 CYTOKINE PROFILE MODULATION BY INTERLEUKIN-10 ADMINISTRATION AUGMENTS GRAFT ARTERIAL DISEASE IN MURINE HEART ALLOGRAFTS. | 2.1 | 0 | Citations (PDF) |
| 620 | MECHANISMS OF CARDIAC ALLOGRAFT SURVIVAL WITH BLOCKADE OF CD40-CD40 LIGAND INTERACTIONS | 2.1 | 0 | Citations (PDF) |
| 621 | Reduction of atherosclerosis in mice by inhibition of CD40 signalling | 37.9 | 878 | Citations (PDF) |
| 622 | Caspase-3-induced gelsolin fragmentation contributes to actin cytoskeletal collapse, nucleolysis, and apoptosis of vascular smooth muscle cells exposed to proinflammatory cytokines | 3.9 | 96 | Citations (PDF) |
| 623 | The Mechanisms by Which Infectious Agents May Contribute to Atherosclerosis and Its Clinical Manifestations | 7.2 | 60 | Citations (PDF) |
| 624 | Absence of Monocyte Chemoattractant Protein-1 Reduces Atherosclerosis in Low Density Lipoprotein Receptor–Deficient Mice | 13.3 | 1,495 | Citations (PDF) |
| 625 | Pravastatin Has Cholesterol-Lowering Independent Effects on the Artery Wall of Atherosclerotic Monkeys | 2.3 | 345 | Citations (PDF) |
| 626 | Macrophages in Human Atheroma Contain PPARγ | 3.4 | 537 | Citations (PDF) |
| 627 | Pattern of Graft- and Host-Specific MHC Class II Expression in Long-Term Murine Cardiac Allografts | 3.4 | 59 | Citations (PDF) |
| 628 | Interferon-γ-Secreting T-Cell Populations in Rejecting Murine Cardiac Allografts | 3.4 | 44 | Citations (PDF) |
| 629 | Circulating Cell Adhesion Molecules Are Correlated With Ultrasound-Based Assessment of Carotid Atherosclerosis | 6.0 | 259 | Citations (PDF) |
| 630 | Expression of Tissue Inhibitor of Metalloproteinases-3 in Human Atheroma and Regulation in Lesion-Associated Cells | 13.1 | 114 | Citations (PDF) |
| 631 | Peroxisome Proliferator-Activated Receptor Gamma Activators Inhibit Gene Expression and Migration in Human Vascular Smooth Muscle Cells | 13.1 | 575 | Citations (PDF) |
| 632 | Lipid Lowering Promotes Accumulation of Mature Smooth Muscle Cells Expressing Smooth Muscle Myosin Heavy Chain Isoforms in Rabbit Atheroma | 13.1 | 144 | Citations (PDF) |
| 633 | The interface of atherosclerosis and thrombosis: basic mechanisms | 2.4 | 85 | Citations (PDF) |
| 634 | Small Mechanical Strains Selectively Suppress Matrix Metalloproteinase-1 Expression by Human Vascular Smooth Muscle Cells | 2.2 | 70 | Citations (PDF) |
| 635 | Structural requirements for inhibition of cytokine-induced endothelial activation by unsaturated fatty acids | 3.6 | 95 | Citations (PDF) |
| 636 | Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. | 10.6 | 602 | Citations (PDF) |
| 637 | Contribution of IFN-γ to acute allograft failure in murine cardiac transplants: Role in vascular thrombosis | 2.1 | 0 | Citations (PDF) |
| 638 | Contribution of IFN-?? to acute allograft failure in murine cardiac transplants: Role in vascular thrombosis | 2.1 | 0 | Citations (PDF) |
| 639 | Generation of Biologically Active IL-1β by Matrix Metalloproteinases: A Novel Caspase-1-Independent Pathway of IL-1β Processing | 0.6 | 591 | Citations (PDF) |
| 640 | The Nuclear Factor κ-B Signaling Pathway Participates in Dysregulation of Vascular Smooth Muscle Cells in Vitroand in Human Atherosclerosis | 2.2 | 247 | Citations (PDF) |
| 641 | Ligation of CD40 Activates Interleukin 1β-converting Enzyme (Caspase-1) Activity in Vascular Smooth Muscle and Endothelial Cells and Promotes Elaboration of Active Interleukin 1β | 2.2 | 110 | Citations (PDF) |
| 642 | Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40–CD40 ligand signaling in atherosclerosis | 7.5 | 719 | Citations (PDF) |
| 643 | 3.C.3 Mechanisms of disruption of the atheromatous plaque | 1.5 | 1 | Citations (PDF) |
| 644 | Atherosclerosis Progression and Vascular Adaptation | 1.1 | 0 | Citations (PDF) |
| 645 | Vascular cells have limited capacities to activate and differentiate T cells: Implications for transplant vascular sclerosis | 1.3 | 11 | Citations (PDF) |
| 646 | Molecular biology of atherosclerosis | 2.2 | 89 | Citations (PDF) |
| 647 | The Unstable Atheroma | 6.0 | 514 | Citations (PDF) |
| 648 | Fas Is Expressed in Human Atherosclerotic Intima and Promotes Apoptosis of Cytokine-Primed Human Vascular Smooth Muscle Cells | 6.0 | 255 | Citations (PDF) |
| 649 | Molecular Determinants of Atherosclerotic Plaque Vulnerability a | 4.0 | 82 | Citations (PDF) |
| 650 | Endothelial Activation Potentiates Neointimal Lesion Formation in the Rabbit Aorta after Balloon Injury | 4.0 | 2 | Citations (PDF) |
| 651 | The molecular bases of restenosis | 5.6 | 127 | Citations (PDF) |
| 652 | Cell dysfunction in atherosclerosis and the ischemic manifestations of coronary artery disease | 1.8 | 45 | Citations (PDF) |
| 653 | Thrombin Promotes Activation of Matrix Metalloproteinase-2 Produced by Cultured Vascular Smooth Muscle Cells | 6.0 | 109 | Citations (PDF) |
| 654 | Evidence for Altered Balance Between Matrix Metalloproteinases and Their Inhibitors in Human Aortic Diseases | 18.0 | 256 | Citations (PDF) |
| 655 | Atherogenic Lipids, Vascular Dysfunction, and Clinical Signs of Ischemic Heart Disease | 18.0 | 80 | Citations (PDF) |
| 656 | Cytokines Score a Knockout | 18.0 | 2 | Citations (PDF) |
| 657 | Roles of Infectious Agents in Atherosclerosis and Restenosis | 18.0 | 444 | Citations (PDF) |
| 658 | Activation of Monocyte/Macrophage Functions Related to Acute Atheroma Complication by Ligation of CD40 | 18.0 | 398 | Citations (PDF) |
| 659 | Mechanical Strain Tightly Controls Fibroblast Growth Factor-2 Release From Cultured Human Vascular Smooth Muscle Cells | 13.1 | 117 | Citations (PDF) |
| 660 | Regulation of Matrix Metalloproteinase Expression in Human Vascular Smooth Muscle Cells by T Lymphocytes | 13.1 | 266 | Citations (PDF) |
| 661 | Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. | 10.6 | 269 | Citations (PDF) |
| 662 | Task force 1. Pathogenesis of coronary disease: The biologic role of risk factors | 2.3 | 185 | Citations (PDF) |
| 663 | Proliferating Arterial Smooth Muscle Cells After Balloon Injury Express TNF-α but Not Interleukin-1 or Basic Fibroblast Growth Factor | 6.0 | 129 | Citations (PDF) |
| 664 | Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use of surrogate end-points | 4.0 | 49 | Citations (PDF) |
| 665 | Macrophages and atherosclerotic plaque stability | 4.0 | 437 | Citations (PDF) |
| 666 | Control of endothelial leukocyte adhesion molecules by fatty acids | 1.3 | 132 | Citations (PDF) |
| 667 | Nitric Oxide Attenuates Vascular Smooth Muscle Cell Activation by Interferon-γ | 2.2 | 122 | Citations (PDF) |
| 668 | Apoptosis of Vascular Smooth Muscle Cells Induced by In Vitro Stimulation With Interferon-γ, Tumor Necrosis Factor–α, and Interleukin-1β | 6.0 | 409 | Citations (PDF) |
| 669 | Components of the protein fraction of oxidized low density lipoprotein stimulate interleukin-1 alpha production by rabbit arterial macrophage-derived foam cells. | 3.6 | 34 | Citations (PDF) |
| 670 | Circumferential Stress and Matrix Metalloproteinase 1 in Human Coronary Atherosclerosis | 6.0 | 229 | Citations (PDF) |
| 671 | Induction of DNA Synthesis by a Single Transient Mechanical Stimulus of Human Vascular Smooth Muscle Cells | 18.0 | 48 | Citations (PDF) |
| 672 | Regulation of Matrix Metalloproteinases and Plasminogen Activator Inhibitor-1 Synthesis by Plasminogen in Cultured Human Vascular Smooth Muscle Cells | 13.1 | 74 | Citations (PDF) |
| 673 | Thrombin Potently Stimulates Cytokine Production in Human Vascular Smooth Muscle Cells but Not in Mononuclear Phagocytes | 13.1 | 93 | Citations (PDF) |
| 674 | A Second Term for the Editors | 13.1 | 0 | Citations (PDF) |
| 675 | THE DIRECT EFFECT OF INJECTABLE CYCLOSPORINE AND ITS VEHICLE, CREMOPHOR, ON ENDOTHELIAL VASCULAR CELL ADHESION MOLECULE-1 EXPRESSION1 RICINOLEIC ACID INHIBITS CORONARY ARTERY ENDOTHELIAL ACTIVATION | 2.1 | 16 | Citations (PDF) |
| 676 | Cytokines Regulate Vascular Functions Related to Stability of the Atherosclerotic Plaque | 2.0 | 308 | Citations (PDF) |
| 677 | Human Vascular Smooth Muscle Cell–Monocyte Interactions and Metalloproteinase Secretion in Culture | 6.0 | 104 | Citations (PDF) |
| 678 | Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. | 10.6 | 1,645 | Citations (PDF) |
| 679 | Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue | 0.6 | 261 | Citations (PDF) |
| 680 | Induction and Stabilization of IκBα by Nitric Oxide Mediates Inhibition of NF-κB | 2.2 | 670 | Citations (PDF) |
| 681 | Nitric Oxide Inhibits Macrophage-Colony Stimulating Factor Gene Transcription in Vascular Endothelial Cells | 2.2 | 162 | Citations (PDF) |
| 682 | Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. | 7.5 | 547 | Citations (PDF) |
| 683 | Omega-3 fatty acids and endothelial leukocyte adhesion molecules | 2.7 | 99 | Citations (PDF) |
| 684 | 963-19 Evidence for Complement Activation by Smooth Muscle Cells in Lesions of Advanced Pulmonary Hypertension (PH) | 2.3 | 0 | Citations (PDF) |
| 685 | Molecular Bases of the Acute Coronary Syndromes | 18.0 | 1,659 | Citations (PDF) |
| 686 | Acute Rejection Accelerates Graft Coronary Disease in Transplanted Rabbit Hearts | 18.0 | 31 | Citations (PDF) |
| 687 | Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. | 10.6 | 164 | Citations (PDF) |
| 688 | Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. | 10.6 | 289 | Citations (PDF) |
| 689 | Human vascular smooth muscle cells poorly co-stimulate and actively inhibit allogeneic CD4+ T cell proliferation in vitro. | 0.6 | 57 | Citations (PDF) |
| 690 | Cytokines Regulate Genes Involved in Atherogenesisa | 4.0 | 56 | Citations (PDF) |
| 691 | Enhanced Expression of Vascular Matrix Metalloproteinases Induced In Vitro by Cytokines and in Regions of Human Atherosclerotic Lesionsa | 4.0 | 244 | Citations (PDF) |
| 692 | Activation of Smooth Muscle and Endothelial Cells following Balloon Injurya | 4.0 | 8 | Citations (PDF) |
| 693 | Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. | 10.6 | 2,286 | Citations (PDF) |
| 694 | The pathogenesis of coronary arteriosclerosis (“chronic rejection”) in transplanted hearts | 1.7 | 32 | Citations (PDF) |
| 695 | Endothelin-1 and Endothelin Receptor mRNA Expression in Normal and Atherosclerotic Human Arteries | 2.1 | 208 | Citations (PDF) |
| 696 | Chapter 20 Future directions and therapeutic approaches | 1.5 | 6 | Citations (PDF) |
| 697 | Chapter 5 Vascular lesion formation | 1.5 | 7 | Citations (PDF) |
| 698 | The role of macrophages in atherogenesis | 4.0 | 113 | Citations (PDF) |
| 699 | Cryopreserved aortic homografts contain viable smooth muscle cells capable of expressing transplantation antigens | 2.6 | 31 | Citations (PDF) |
| 700 | Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages. | 10.6 | 183 | Citations (PDF) |
| 701 | Atherogenic Diets Enhance Endotoxin-Stimulated Interleukin-1 and Tumor Necrosis Factor Gene Expression in Rabbit Aortae , | 2.9 | 76 | Citations (PDF) |
| 702 | Do Vascular Wall Cytokines Promote Atherogenesis? | 1.0 | 17 | Citations (PDF) |
| 703 | Increased apolipoprotein E and c-fms gene expression without elevated interleukin 1 or 6 mRNA levels indicates selective activation of macrophage functions in advanced human atheroma. | 7.5 | 111 | Citations (PDF) |
| 704 | Inducible gene expression in vascular wall cells and lesional leukocytes | 1.8 | 4 | Citations (PDF) |
| 705 | Functional significance of human vascular smooth muscle cell-derived interleukin 1 in paracrine and autocrine regulation pathways | 3.1 | 83 | Citations (PDF) |
| 706 | Cardiac transplant graft arteriosclerosis | 7.2 | 40 | Citations (PDF) |
| 707 | Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS | 2.7 | 169 | Citations (PDF) |
| 708 | Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. | 10.6 | 345 | Citations (PDF) |
| 709 | Cytokines as Modulators of Cell Proliferation in Fibrotic Diseases | 3.2 | 62 | Citations (PDF) |
| 710 | Adult human vascular endothelial cells express the IL6 gene differentially in response to LPS or IL1 | 2.5 | 148 | Citations (PDF) |
| 711 | Regulation of smooth muscle profileration in hyperplastic arterial lesions | 1.8 | 1 | Citations (PDF) |
| 712 | Observations on human smooth muscle cell cultures from hyperplastic lesions of prosthetic bypass grafts: Production of a platelet-derived growth factor—like mitogen and expression of a gene for a platelet-derived growth factor receptor—A preliminary study | 1.8 | 25 | Citations (PDF) |
| 713 | PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells | 33.6 | 961 | Citations (PDF) |
| 714 | Observations on human smooth muscle cell cultures from hyperplastic lesions of prosthetic bypass grafts: Production of a platelet-derived growth factor[mdash ]like mitogen and expression of a gene for a platelet-derived growth factor receptor[mdash ]A preliminary study | 1.8 | 38 | Citations (PDF) |
| 715 | Immune interferon inhibits proliferation and induces 2'-5'-oligoadenylate synthetase gene expression in human vascular smooth muscle cells. | 10.6 | 110 | Citations (PDF) |
| 716 | Production of Platelet-Derived Growth Factor–like Mitogen by Smooth-Muscle Cells from Human Atheroma | 34.5 | 340 | Citations (PDF) |
| 717 | Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. | 10.6 | 504 | Citations (PDF) |
| 718 | IL-2 rapidly induces natural killer cell adhesion to human endothelial cells. A potential mechanism for endothelial injury. | 0.6 | 85 | Citations (PDF) |
| 719 | Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells. | 9.3 | 228 | Citations (PDF) |
| 720 | Mesenchymal Target Cell Specificity of Egg Granuloma-Derived Fibroblast Growth Factor in Schistosomiasis | 3.7 | 15 | Citations (PDF) |
| 721 | The active roles of cells of the blood vessel wall in health and disease | 9.4 | 17 | Citations (PDF) |
| 722 | Elaboration by mammalian mesenchymal cells infected with Trypanosoma cruzi of a fibroblast-stimulating factor that may contribute to chagasic cardiomyopathy | 2.7 | 12 | Citations (PDF) |
| 723 | Adult human endothelial cell coverage of small-caliber dacron and polytetrafluoroethylene vascular prostheses in vitro | 1.6 | 87 | Citations (PDF) |
| 724 | INDUCIBLE EXPRESSION OF CLASS II MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS AND THE IMMUNOGENICITY OF VASCULAR ENDOTHELIUM | 2.1 | 202 | Citations (PDF) |
| 725 | A neuraminidase from Trypanosoma cruzi removes sialic acid from the surface of mammalian myocardial and endothelial cells. | 10.6 | 94 | Citations (PDF) |
| 726 | Inducible interleukin-1 gene expression in human vascular smooth muscle cells. | 10.6 | 248 | Citations (PDF) |
| 727 | Lipoproteins increase growth of mitogen-stimulated arterial smooth muscle cells | 4.1 | 87 | Citations (PDF) |
| 728 | Analysis of the mitogenic effect of fetuin preparations on arterial smooth muscle cells: The role of contaminant platelet-derived growth factor | 4.1 | 31 | Citations (PDF) |
| 729 | The role of Protein breakdown in growth, quiescence, and starvation of vascular smooth muscle cells | 4.1 | 28 | Citations (PDF) |
| 730 | Long-term culture of contractile mammalian heart cells in a defined serum-free medium that limits non-muscle cell proliferation* | 3.8 | 51 | Citations (PDF) |
| 731 | Culture of quiescent arterial smooth muscle cells in a defined serum‐free medium | 4.1 | 225 | Citations (PDF) |
| 732 | Comparison of the control and pathways for degradation of the acetylcholine receptor and average protein in cultured muscle cells | 4.1 | 37 | Citations (PDF) |
| 733 | Morphological changes in cultured myotubes treated with agents that interfere with lysosomal function | 2.7 | 20 | Citations (PDF) |
| 734 | Effects of chymostatin and other proteinase inhibitors on protein breakdown and proteolytic activities in muscle | 3.8 | 43 | Citations (PDF) |
| 735 | Degradation of the acetylcholine receptor in cultured muscle cells: Selective inhibitors and the fate of undegraded receptors | 33.6 | 114 | Citations (PDF) |
| 736 | Reduction of protein degradation and atrophy in cultured fetal mouse hearts by leupeptin. | 3.0 | 20 | Citations (PDF) |
| 737 | Increased myocardial ischemic injury during insulin induced hypoglycemia | 1.8 | 2 | Citations (PDF) |
| 738 | Reduction of Infarct Size Following Coronary Occlusion | 13.1 | 3 | Citations (PDF) |
| 739 | Effect of pharmacologic agents on the function of the ischemic heart | 1.8 | 45 | Citations (PDF) |
| 740 | Effect of practolol on the extent of myocardial ischaemic injury after experimental coronary occlusion and its effects on ventricular function in the normal and ischaemic heart | 5.5 | 99 | Citations (PDF) |
| 741 | Reduction of Experimental Myocardial Infarct Size by Corticosteroid Administration | 10.6 | 270 | Citations (PDF) |
| 742 | Reduction by Hyaluronidase of Myocardial Necrosis following Coronary Artery Occlusion | 18.0 | 154 | Citations (PDF) |
| 743 | Effects of Intraaortic Balloon Counterpulsation on the Severity of Myocardial Ischemic Injury following Acute Coronary Occlusion | 18.0 | 181 | Citations (PDF) |
| 744 | Effect of Glucose-Insulin-Potassium Infusion on Myocardial Infarction following Experimental Coronary Artery Occlusion | 18.0 | 309 | Citations (PDF) |
| 745 | Precordial S-T segment elevation mapping: An atraumatic method for assessing alterations in the extent of myocardial ischemic injury | 1.8 | 391 | Citations (PDF) |
| 746 | Reduction in experimental myocardial infarct size by glucose-insulin-potassium administration | 1.8 | 3 | Citations (PDF) |
| 747 | Salvage of myocardial tissue by coronary artery reperfusion following acute coronary occlusion | 1.8 | 9 | Citations (PDF) |
| 748 | Coronary Artery Reperfusion | 10.6 | 332 | Citations (PDF) |
| 749 | Requiem for the ‘vulnerable plaque’ | 2.2 | 246 | Citations (PDF) |
| 750 | Title is missing! 0 | | 2 | Citations (PDF) |
| 751 | Eicosapentaenoic acid limits the more rapid oxidation of lipoprotein(a) compared with other apolipoprotein B particles | 5.5 | 3 | Citations (PDF) |
| 752 | Global cardiometabolic alliance: A clinical and research initiative addressing the 21st century pandemic of insulin resistance‐associated disease | 4.5 | 3 | Citations (PDF) |
| 753 | Inflammation in atherosclerosis: Lessons and therapeutic implications | 22.6 | 50 | Citations (PDF) |
| 754 | Clonal Hematopoiesis and Incident Heart Failure | 11.1 | 8 | Citations (PDF) |
| 755 | Cellular and molecular imaging of coronary atherosclerosis: clinical applications | 2.2 | 2 | Citations (PDF) |
| 756 | Mast cells in cardiovascular disease: Fibrosis, angiogenesis and atherogenesis | 5.6 | 1 | Citations (PDF) |
| 757 | Lipoprotein(a)—To test or not to test, not a dilemma but a mandate | 3.1 | 3 | Citations (PDF) |
| 758 | Unraveling atherosclerosis through single-cell RNA sequencing: insights into cellular heterogeneity and disease mechanisms | 0.7 | 1 | Citations (PDF) |
| 759 | Nontraditional Coronary Risk Factors and Vascular Biology: The Frontiers of Preventive Cardiology | 1.7 | 0 | Citations (PDF) |
| 760 | The Twisted Tale of Interleukin-18 in Atherosclerosis | 3.3 | 0 | Citations (PDF) |
| 761 | Echoes of inflammation: cardiovascular risk in giant cell arteritis | 2.0 | 0 | Citations (PDF) |
| 762 | 26-A-13916-ACC RATES OF LIPOPROTEIN(A) OXIDATION INCREASE AT ELEVATED LEVELS IN A NON-LINEAR FASHION AND INHIBITED BY EICOSAPENTAENOIC ACID (EPA) | 2.3 | 0 | Citations (PDF) |
| 763 | 26-A-8713-ACC ATORVASTATIN METABOLITES WITH ANTIOXIDANT ACTIONS LIMIT RAPID OXIDATION OF LIPOPROTEIN(A)-ENRICHED PLASMA MORE EFFECTIVELY THAN OTHER STATINS | 2.3 | 0 | Citations (PDF) |
| 764 | Gamut of Patients Referred to Cardiology for Question of Clonal Hematopoiesis | 2.9 | 0 | Citations (PDF) |
| 765 | Secondary Prevention After Myocardial Infarction in the United States | 2.3 | 0 | Citations (PDF) |
| 766 | The price of cardiovascular risk reclassification with Lp(a) testing | 3.1 | 0 | Citations (PDF) |
| 767 | Eugene Braunwald (1929–2026) | 35.5 | 0 | Citations (PDF) |
| 768 | Clinical and genetic landscape of individuals evaluated in a CHIP cardiology clinic: A single-center experience, 2020 to 2025. | 16.9 | 0 | Citations (PDF) |
| 769 | A quantitative method to estimate free interleukin-6 among patients treated with the interleukin-6 ligand inhibitor ziltivekimab: comparison to C-reactive protein with implications for the ZEUS, HERMES, and ARTEMIS cardiovascular outcomes trials | 1.5 | 0 | Citations (PDF) |
| 770 | Eugene Braunwald | 2.3 | 0 | Citations (PDF) |
